Stephen Hauser, MD
Professor
Neurology
School of Medicine

A neuroimmunologist, Dr. Hauser’s research has advanced our understanding of the genetic basis, immune mechanisms, and treatment of multiple sclerosis (MS). His work led to the development of B cell therapies for MS patients, representing a powerful new approach for treating all forms of the disease and the first therapy of proven value for progressive MS.

Dr. Hauser is a member of the National Academy of Medicine and a fellow of the American Academy of Arts and Sciences and the American Academy of Physicians. He is an editor of the medical textbook Harrison’s Principles of Internal Medicine. Previously chairman of the Department of Neurology at UCSF for 25 years, he has also served as President of the American Neurological Association, President of the Medical Staff at UCSF, Chair of the Research Advisory Committee for the U.S. Department of Veterans Affairs, and editor-in-chief of Annals of Neurology. He also served the Obama administration as a member of the Presidential Commission for the Study of Bioethical Issues charged with advising the President on issues that may emerge from advances in biomedicine and related areas of science and technology.

Dr. Hauser has received numerous awards and honors for his work, including the Jacob Javits Neuroscience Investigator Award, the John Dystel Prize for Multiple Sclerosis Research (2008), the Charcot Award (2013), the Taubman Prize for Excellence in Translational Medical Research (2017), and the Scientific Breakthrough Award from the American Brain Foundation (2022).

Dr. Hauser is a graduate of the Massachusetts Institute of Technology (Phi Beta Kappa) and Harvard Medical School (Magna Cum Laude). He trained in internal medicine at the New York Hospital–Cornell Medical Center, in neurology at the Massachusetts General Hospital, and in immunology at Harvard Medical School and the Institute Pasteur in Paris, France. He was a faculty member at Harvard Medical School before moving to UCSF.

• Patient-reported outcome parameters and disability worsening in progressive multiple sclerosis.
  Multiple sclerosis and related disorders 2023 Abdelhak A, Antweiler K, Kowarik MC, Senel M, Havla J, Zettl UK, Kleiter I, Hoshi MM, Skripuletz T, Haarmann A, Stahmann A, Huss A, Gingele S, Krumbholz M, Selge C, Friede T, Ludolph AC, Overell J, …
• Ocrelizumab exposure in relapsing-remitting multiple sclerosis: 10-year analysis of the phase 2 randomized clinical trial and its extension.
  Journal of neurology 2023 Kappos L, Traboulsee A, Li DKB, Bar-Or A, Barkhof F, Montalban X, Leppert D, Baldinotti A, Schneble HM, Koendgen H, Sauter A, Wang Q, Hauser SL
• A metagenomics method for the quantitative detection of bacterial pathogens causing hospital-associated and ventilator-associated pneumonia.
  Microbiology spectrum 2023 Hauser S, Lazarevic V, Tournoud M, Ruppé E, Santiago Allexant E, Guigon G, Schicklin S, Lanet V, Girard M, Mirande C, Gervasi G, Schrenzel J
• Efficacy and safety of four-year ofatumumab treatment in relapsing multiple sclerosis: The ALITHIOS open-label extension.
  Multiple sclerosis (Houndmills, Basingstoke, England) 2023 Hauser SL, Zielman R, Das Gupta A, Xi J, Stoneman D, Karlsson G, Robertson D, Cohen JA, Kappos L
• Progressive multifocal leukoencephalopathy in a patient with relapsing multiple sclerosis treated with ocrelizumab: A case report.
  European journal of neurology 2023 Puig-Casadevall M, Álvarez-Bravo G, Varela AQ, Robles-Cedeño R, Sànchez Cirera L, Miguela A, Laguillo G, Montalban X, Hauser SL, Ramió-Torrentà L
• The Development of Ofatumumab, a Fully Human Anti-CD20 Monoclonal Antibody for Practical Use in Relapsing Multiple Sclerosis Treatment.
  Neurology and therapy 2023 Hauser SL, Kappos L, Bar-Or A, Wiendl H, Paling D, Williams M, Gold R, Chan A, Milo R, Das Gupta A, Karlsson G, Sullivan R, Graham G, Merschhemke M, Häring DA, Vermersch P
• Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect disease activity in multiple sclerosis.
  medRxiv : the preprint server for health sciences 2023 Chitnis T, Qureshi F, Gehman VM, Becich M, Bove R, Cree BAC, Gomez R, Hauser SL, Henry RG, Katrib A, Lokhande H, Paul A, Caillier SJ, Santaniello A, Sattarnezhad N, Saxena S, Weiner H, Yano H, …
• Blood neurofilament light levels predict non-relapsing progression following anti-CD20 therapy in relapsing and primary progressive multiple sclerosis: findings from the ocrelizumab randomised, double-blind phase 3 clinical trials.
  EBioMedicine 2023 Bar-Or A, Thanei GA, Harp C, Bernasconi C, Bonati U, Cross AH, Fischer S, Gaetano L, Hauser SL, Hendricks R, Kappos L, Kuhle J, Leppert D, Model F, Sauter A, Koendgen H, Jia X, Herman AE
• A Predictive Autoantibody Signature in Multiple Sclerosis.
  medRxiv : the preprint server for health sciences 2023 Zamecnik CR, Sowa GM, Abdelhak A, Dandekar R, Bair RD, Wade KJ, Bartley CM, Tubati A, Gomez R, Fouassier C, Gerungan C, Alexander J, Wapniarski AE, Loudermilk RP, Eggers EL, Zorn KC, Ananth K, …
• Integration of epigenetic and genetic profiles identifies multiple sclerosis disease-critical cell types and genes.
  Communications biology 2023 Ma Q, Shams H, Didonna A, Baranzini SE, Cree BAC, Hauser SL, Henry RG, Oksenberg JR
• Association of Higher Ocrelizumab Exposure With Reduced Disability Progression in Multiple Sclerosis.
  Neurology(R) neuroimmunology & neuroinflammation 2023 Hauser SL, Bar-Or A, Weber MS, Kletzl H, Günther A, Manfrini M, Model F, Mercier F, Petry C, Wing Q, Koendgen H, Smith T, Kappos L
• Polygenic risk score association with multiple sclerosis susceptibility and phenotype in Europeans.
  Brain : a journal of neurology 2023 Shams H, Shao X, Santaniello A, Kirkish G, Harroud A, Ma Q, Isobe N, University of California San Francisco MS-EPIC Team, Schaefer CA, McCauley JL, Cree BAC, Didonna A, Baranzini SE, Patsopoulos NA, …
• CAR-T Cell-Mediated B-Cell Depletion in Central Nervous System Autoimmunity.
  Neurology(R) neuroimmunology & neuroinflammation 2023 Gupta S, Simic M, Sagan SA, Shepherd C, Duecker J, Sobel RA, Dandekar R, Wu GF, Wu W, Pak JE, Hauser SL, Lim W, Wilson MR, Zamvil SS
• Remote Observational Research for Multiple Sclerosis: A Natural Experiment.
  Neurology(R) neuroimmunology & neuroinflammation 2022 Bove R, Poole S, Cuneo R, Gupta S, Sabatino J, Harms M, Cooper T, Rowles W, Miller N, Gomez R, Lincoln R, McPolin K, Powers K, Santaniello A, Renschen A, Bevan CJ, Gelfand JM, Goodin DS, Guo CY, Romeo…
• Association of daily physical activity with brain volumes and cervical spinal cord areas in multiple sclerosis.
  Multiple sclerosis (Houndmills, Basingstoke, England) 2022 Block VJ, Cheng S, Juwono J, Cuneo R, Kirkish G, Alexander AM, Khan M, Akula A, Caverzasi E, Papinutto N, Stern WA, Pletcher MJ, Marcus GM, Olgin JE, Hauser SL, Gelfand JM, Bove R, Cree BA, Henry RG
• Neural correlates of digital measures shown by structural MRI: a post-hoc analysis of a smartphone-based remote assessment feasibility study in multiple sclerosis.
  Journal of neurology 2022 Ganzetti M, Graves JS, Holm SP, Dondelinger F, Midaglia L, Gaetano L, Craveiro L, Lipsmeier F, Bernasconi C, Montalban X, Hauser SL, Lindemann M
• Differences in Age-related Retinal and Cortical Atrophy Rates in Multiple Sclerosis.
  Neurology 2022 Cordano C, Nourbakhsh B, Yiu HH, Papinutto N, Caverzasi E, Abdelhak A, Oertel FC, Beaudry-Richard A, Santaniello A, Sacco S, Bennett DJ, Gomez A, Sigurdson CJ, Hauser SL, Magliozzi R, Cree BAC, Henry …
• KIR+CD8+ T cells suppress pathogenic T cells and are active in autoimmune diseases and COVID-19.
  Science (New York, N.Y.) 2022 Li J, Zaslavsky M, Su Y, Guo J, Sikora MJ, van Unen V, Christophersen A, Chiou SH, Chen L, Li J, Ji X, Wilhelmy J, McSween AM, Palanski BA, Mallajosyula VVA, Bracey NA, Dhondalay GKR, Bhamidipati K, …
• Challenges to Longitudinal Characterization of Lower Urinary Tract Dysfunction in Multiple Sclerosis.
  Multiple sclerosis and related disorders 2022 Kaplan TB, Gopal A, Block VJ, Suskind AM, Zhao C, Polgar-Turcsanyi M, Saraceno TJ, Gomez R, Santaniello A, Consortium S, Ayoubi NE, Cree BAC, Hauser SL, Weiner H, Chitnis T, Khoury S, Bove R
• Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II Trials.
  Frontiers in immunology 2022 Ziemssen T, Arnold DL, Alvarez E, Cross AH, Willi R, Li B, Kukkaro P, Kropshofer H, Ramanathan K, Merschhemke M, Kieseier B, Su W, Häring DA, Hauser SL, Kappos L, Kuhle J
• Reply to "Spinal Cord Atrophy Is a Preclinical Marker of Progressive MS".
  Annals of neurology 2022 Bischof A, Papinutto N, Keshavan A, Rajesh A, Kirkish G, Zhang X, Mallott JM, Asteggiano C, Sacco S, Gundel TJ, Zhao C, Stern WA, Caverzasi E, Zhou Y, Gomez R, Ragan NR, Santaniello A, Zhu AH, Juwono …
• Efficacy and safety of ofatumumab in recently diagnosed, treatment-naive patients with multiple sclerosis: Results from ASCLEPIOS I and II.
  Multiple sclerosis (Houndmills, Basingstoke, England) 2022 Gärtner J, Hauser SL, Bar-Or A, Montalban X, Cohen JA, Cross AH, Deiva K, Ganjgahi H, Häring DA, Li B, Pingili R, Ramanathan K, Su W, Willi R, Kieseier B, Kappos L
• Simultaneous assessment of regional distributions of atrophy across the neuraxis in MS patients.
  NeuroImage. Clinical 2022 Freund P, Papinutto N, Bischof A, Azzarito M, Kirkish G, Ashburner J, Thompson A, Hauser SL, Henry RG
• Multiple sclerosis: two decades of progress.
  The Lancet. Neurology 2022 Cree BAC, Oksenberg JR, Hauser SL
• Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years.
  Multiple sclerosis (Houndmills, Basingstoke, England) 2022 Hauser SL, Cross AH, Winthrop K, Wiendl H, Nicholas J, Meuth SG, Giacomini PS, Saccà F, Mancione L, Zielman R, Bagger M, Das Gupta A, Häring DA, Jehl V, Kieseier BC, Pingili R, Stoneman D, Su W, Willi…
• Generation of two SPAST knockout human induced pluripotent stem cell lines to create a model for Hereditary Spastic Paraplegia type 4.
  Stem cell research 2022 Korneck M, Wiora L, Schöls L, Hauser S
• Building a Precision Medicine Delivery Platform for Clinics: The University of California, San Francisco, BRIDGE Experience.
  Journal of medical Internet research 2022 Bove R, Schleimer E, Sukhanov P, Gilson M, Law SM, Barnecut A, Miller BL, Hauser SL, Sanders SJ, Rankin KP
• Search for Relativistic Magnetic Monopoles with Eight Years of IceCube Data.
  Physical review letters 2022 Abbasi R, Ackermann M, Adams J, Aguilar JA, Ahlers M, Ahrens M, Alispach C, Alves AA, Amin NM, An R, Andeen K, Anderson T, Anton G, Argüelles C, Ashida Y, Axani S, Bai X, Balagopal V A, Barbano A, …
• Spinal Cord Atrophy Predicts Progressive Disease in Relapsing Multiple Sclerosis.
  Annals of neurology 2022 Bischof A, Papinutto N, Keshavan A, Rajesh A, Kirkish G, Zhang X, Mallott JM, Asteggiano C, Sacco S, Gundel TJ, Zhao C, Stern WA, Caverzasi E, Zhou Y, Gomez R, Ragan NR, Santaniello A, Zhu AH, Juwono …
• Human KIR + CD8 + T cells target pathogenic T cells in Celiac disease and are active in autoimmune diseases and COVID-19.
  bioRxiv : the preprint server for biology 2021 Li J, Zaslavsky M, Su Y, Sikora MJ, van Unen V, Christophersen A, Chiou SH, Chen L, Li J, Ji X, Wilhelmy J, McSween AM, Palanski BA, Aditya Mallajosyula VV, Dhondalay GKR, Bhamidipati K, Pai J, Kipp …
• Specific hypomethylation programs underpin B cell activation in early multiple sclerosis.
  Proceedings of the National Academy of Sciences of the United States of America 2021 Ma Q, Caillier SJ, Muzic S, University of California San Francisco MS-EPIC Team, Wilson MR, Henry RG, Cree BAC, Hauser SL, Didonna A, Oksenberg JR
• Author Correction: Pan-viral serology implicates enteroviruses in acute flaccid myelitis.
  Nature medicine 2021 Schubert RD, Hawes IA, Ramachandran PS, Ramesh A, Crawford ED, Pak JE, Wu W, Cheung CK, O'Donovan BD, Tato CM, Lyden A, Tan M, Sit R, Sowa GM, Sample HA, Zorn KC, Banerji D, Khan LM, Bove R, Hauser SL…
• Safety of Ocrelizumab in Patients With Relapsing and Primary Progressive Multiple Sclerosis.
  Neurology 2021 Hauser SL, Kappos L, Montalban X, Craveiro L, Chognot C, Hughes R, Koendgen H, Pasquarelli N, Pradhan A, Prajapati K, Wolinsky JS
• Electronic Health Record Technology Designed for the Clinical Encounter: MS NeuroShare.
  Neurology. Clinical practice 2021 Bove R, Bruce CA, Lunders CK, Pearce JR, Liu J, Schleimer E, Hauser SL, Stewart WF, Jones JB
• Curing Multiple Sclerosis: How to Know When We're There.
  Annals of neurology 2021 Hauser SL
• A smartphone sensor-based digital outcome assessment of multiple sclerosis.
  Multiple sclerosis (Houndmills, Basingstoke, England) 2021 Montalban X, Graves J, Midaglia L, Mulero P, Julian L, Baker M, Schadrack J, Gossens C, Ganzetti M, Scotland A, Lipsmeier F, van Beek J, Bernasconi C, Belachew S, Lindemann M, Hauser SL
• High Resolution Haplotype Analyses of Classical HLA Genes in Families With Multiple Sclerosis Highlights the Role of HLA-DP Alleles in Disease Susceptibility.
  Frontiers in immunology 2021 Osoegawa K, Creary LE, Montero-Martín G, Mallempati KC, Gangavarapu S, Caillier SJ, Santaniello A, Isobe N, Hollenbach JA, Hauser SL, Oksenberg JR, Fernández-Vina MA
• Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry.
  European journal of neurology 2021 Butzkueven H, Spelman T, Horakova D, Hughes S, Solaro C, Izquierdo G, Kubala Havrdová E, Grand'Maison F, Prat A, Girard M, Hupperts R, Onofrj M, Lugaresi A, Taylor B, MSBase Study Group, Giovannoni G,…
• Risk of requiring a walking aid after 6.5 years of ocrelizumab treatment in patients with relapsing multiple sclerosis: Data from the OPERA I and OPERA II trials.
  European journal of neurology 2021 Giovannoni G, Kappos L, de Seze J, Hauser SL, Overell J, Koendgen H, Manfrini M, Wang Q, Wolinsky JS
• Cell type-specific transcriptomics identifies neddylation as a novel therapeutic target in multiple sclerosis.
  Brain : a journal of neurology 2021 Kim K, Pröbstel AK, Baumann R, Dyckow J, Landefeld J, Kogl E, Madireddy L, Loudermilk R, Eggers EL, Singh S, Caillier SJ, Hauser SL, Cree BAC, UCSF MS-EPIC Team, Schirmer L, Wilson MR, Baranzini SE
• Antigen Presentation by B Cells in Multiple Sclerosis.
  The New England journal of medicine 2021 Zamvil SS, Hauser SL
• Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO.
  British journal of clinical pharmacology 2020 Gibiansky E, Petry C, Mercier F, Günther A, Herman A, Kappos L, Hauser S, Yamamoto Y, Wang Q, Model F, Kletzl H
• An electronic, unsupervised patient-reported Expanded Disability Status Scale for multiple sclerosis.
  Multiple sclerosis (Houndmills, Basingstoke, England) 2020 Romeo AR, Rowles WM, Schleimer ES, Barba P, Hsu WY, Gomez R, Santaniello A, Zhao C, Pearce JR, Jones JB, Cree BC, Hauser SL, Gelfand JM, Stewart WF, Goodin DS, Bove RM
• Gut microbiota-specific IgA+ B cells traffic to the CNS in active multiple sclerosis.
  Science immunology 2020 Pröbstel AK, Zhou X, Baumann R, Wischnewski S, Kutza M, Rojas OL, Sellrie K, Bischof A, Kim K, Ramesh A, Dandekar R, Greenfield AL, Schubert RD, Bisanz JE, Vistnes S, Khaleghi K, Landefeld J, Kirkish …
• Retinal INL Thickness in Multiple Sclerosis: A Mere Marker of Neurodegeneration?
  Annals of neurology 2020 Cordano C, Yiu HH, Oertel FC, University of California, San Francisco MS-EPIC Team, Gelfand JM, Hauser SL, Cree BAC, Green AJ
• Neurite Orientation Dispersion and Density Imaging for Assessing Acute Inflammation and Lesion Evolution in MS.
  AJNR. American journal of neuroradiology 2020 Sacco S, Caverzasi E, Papinutto N, Cordano C, Bischof A, Gundel T, Cheng S, Asteggiano C, Kirkish G, Mallott J, Stern WA, Bastianello S, Bove RM, Gelfand JM, Goodin DS, Green AJ, Waubant E, Wilson MR,…
• Role of B Cells in Multiple Sclerosis and Related Disorders.
  Annals of neurology 2020 Comi G, Bar-Or A, Lassmann H, Uccelli A, Hartung HP, Montalban X, Sørensen PS, Hohlfeld R, Hauser SL, Expert Panel of the 27th Annual Meeting of the European Charcot Foundation
• Long-term follow-up from the ORATORIO trial of ocrelizumab for primary progressive multiple sclerosis: a post-hoc analysis from the ongoing open-label extension of the randomised, placebo-controlled, phase 3 trial.
  The Lancet. Neurology 2020 Wolinsky JS, Arnold DL, Brochet B, Hartung HP, Montalban X, Naismith RT, Manfrini M, Overell J, Koendgen H, Sauter A, Bennett I, Hubeaux S, Kappos L, Hauser SL
• CHIP mutations affect the heat shock response differently in human fibroblasts and iPSC-derived neurons.
  Disease models & mechanisms 2020 Schuster S, Heuten E, Velic A, Admard J, Synofzik M, Ossowski S, Macek B, Hauser S, Schöls L
• Two genetic variants explain the association of European ancestry with multiple sclerosis risk in African-Americans.
  Scientific reports 2020 Nakatsuka N, Patterson N, Patsopoulos NA, Altemose N, Tandon A, Beecham AH, McCauley JL, Isobe N, Hauser S, De Jager PL, Hafler DA, Oksenberg JR, Reich D
• eV-Scale Sterile Neutrino Search Using Eight Years of Atmospheric Muon Neutrino Data from the IceCube Neutrino Observatory.
  Physical review letters 2020 Aartsen MG, Abbasi R, Ackermann M, Adams J, Aguilar JA, Ahlers M, Ahrens M, Alispach C, Amin NM, Andeen K, Anderson T, Ansseau I, Anton G, Argüelles C, Auffenberg J, Axani S, Bagherpour H, Bai X, …
• Ataxin-1 regulates B cell function and the severity of autoimmune experimental encephalomyelitis.
  Proceedings of the National Academy of Sciences of the United States of America 2020 Didonna A, Canto Puig E, Ma Q, Matsunaga A, Ho B, Caillier SJ, Shams H, Lee N, Hauser SL, Tan Q, Zamvil SS, Oksenberg JR
• Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials.
  JAMA neurology 2020 Kappos L, Wolinsky JS, Giovannoni G, Arnold DL, Wang Q, Bernasconi C, Model F, Koendgen H, Manfrini M, Belachew S, Hauser SL
• Progress in Multiple Sclerosis Research: An Example of Bedside to Bench.
  JAMA 2020 Hauser SL
• A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis.
  Proceedings of the National Academy of Sciences of the United States of America 2020 Ramesh A, Schubert RD, Greenfield AL, Dandekar R, Loudermilk R, Sabatino JJ, Koelzer MT, Tran EB, Koshal K, Kim K, Pröbstel AK, Banerji D, University of California, San Francisco MS-EPIC Team, Guo CY,…
• Ofatumumab versus Teriflunomide in Multiple Sclerosis.
  The New England journal of medicine 2020 Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, …
• High-resolution epitope mapping of anti-Hu and anti-Yo autoimmunity by programmable phage display.
  Brain communications 2020 O'Donovan B, Mandel-Brehm C, Vazquez SE, Liu J, Parent AV, Anderson MS, Kassimatis T, Zekeridou A, Hauser SL, Pittock SJ, Chow E, Wilson MR, DeRisi JL
• Imaging correlates of visual function in multiple sclerosis.
  PloS one 2020 Caverzasi E, Cordano C, Zhu AH, Zhao C, Bischof A, Kirkish G, Bennett DJ, Devereux M, Baker N, Inman J, Yiu HH, Papinutto N, Gelfand JM, Cree BAC, Hauser SL, Henry RG, Green AJ
• Five years of ocrelizumab in relapsing multiple sclerosis: OPERA studies open-label extension.
  Neurology 2020 Hauser SL, Kappos L, Arnold DL, Bar-Or A, Brochet B, Naismith RT, Traboulsee A, Wolinsky JS, Belachew S, Koendgen H, Levesque V, Manfrini M, Model F, Hubeaux S, Mehta L, Montalban X
• Treatment of Multiple Sclerosis: A Review.
  The American journal of medicine 2020 Hauser SL, Cree BAC
• A Precision Medicine Tool for Patients With Multiple Sclerosis (the Open MS BioScreen): Human-Centered Design and Development.
  Journal of medical Internet research 2020 Schleimer E, Pearce J, Barnecut A, Rowles W, Lizee A, Klein A, Block VJ, Santaniello A, Renschen A, Gomez R, Keshavan A, Gelfand JM, Henry RG, Hauser SL, Bove R
• Serum antibodies to phosphatidylcholine in MS.
  Neurology(R) neuroimmunology & neuroinflammation 2020 Sádaba MC, Rothhammer V, Muñoz Ú, Sebal C, Escudero E, Kivisäkk P, Garcia Sanchez MI, Izquierdo G, Hauser SL, Baranzini SE, Oksenberg JR, Álvarez-Lafuente R, Bakshi R, Weiner HL, Quintana FJ
• Brain MRI Predicts Worsening Multiple Sclerosis Disability over 5 Years in the SUMMIT Study.
  Journal of neuroimaging : official journal of the American Society of Neuroimaging 2020 Bakshi R, Healy BC, Dupuy SL, Kirkish G, Khalid F, Gundel T, Asteggiano C, Yousuf F, Alexander A, Hauser SL, Weiner HL, Henry RG, SUMMIT consortium
• Anti-CD20 therapy depletes activated myelin-specific CD8+ T cells in multiple sclerosis.
  Proceedings of the National Academy of Sciences of the United States of America 2019 Sabatino JJ, Wilson MR, Calabresi PA, Hauser SL, Schneck JP, Zamvil SS
• Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years.
  JAMA neurology 2019 Cantó E, Barro C, Zhao C, Caillier SJ, Michalak Z, Bove R, Tomic D, Santaniello A, Häring DA, Hollenbach J, Henry RG, Cree BAC, Kappos L, Leppert D, Hauser SL, Benkert P, Oksenberg JR, Kuhle J
• Pan-viral serology implicates enteroviruses in acute flaccid myelitis.
  Nature medicine 2019 Schubert RD, Hawes IA, Ramachandran PS, Ramesh A, Crawford ED, Pak JE, Wu W, Cheung CK, O'Donovan BD, Tato CM, Lyden A, Tan M, Sit R, Sowa GM, Sample HA, Zorn KC, Banerji D, Khan LM, Bove R, Hauser SL…
• Correction: Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study.
  Journal of medical Internet research 2019 Midaglia L, Mulero P, Montalban X, Graves J, Hauser SL, Julian L, Baker M, Schadrack J, Gossens C, Scotland A, Lipsmeier F, van Beek J, Bernasconi C, Belachew S, Lindemann M
• Telomere Length Is Associated with Disability Progression in Multiple Sclerosis.
  Annals of neurology 2019 Krysko KM, Henry RG, Cree BAC, Lin J, University of California, San Francisco MS-EPIC Team, Caillier S, Santaniello A, Zhao C, Gomez R, Bevan C, Smith DL, Stern W, Kirkish G, Hauser SL, Oksenberg JR, …
• Intersubject Variability and Normalization Strategies for Spinal Cord Total Cross-Sectional and Gray Matter Areas.
  Journal of neuroimaging : official journal of the American Society of Neuroimaging 2019 Papinutto N, Asteggiano C, Bischof A, Gundel TJ, Caverzasi E, Stern WA, Bastianello S, Hauser SL, Henry RG
• Contribution of normal aging to brain atrophy in MS.
  Neurology(R) neuroimmunology & neuroinflammation 2019 Azevedo CJ, Cen SY, Jaberzadeh A, Zheng L, Hauser SL, Pelletier D
• Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis.
  Neurology 2019 Barkhof F, Kappos L, Wolinsky JS, Li DKB, Bar-Or A, Hartung HP, Belachew S, Han J, Julian L, Sauter A, Napieralski J, Koendgen H, Hauser SL
• Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis.
  Brain : a journal of neurology 2019 Elliott C, Belachew S, Wolinsky JS, Hauser SL, Kappos L, Barkhof F, Bernasconi C, Fecker J, Model F, Wei W, Arnold DL
• Adherence and Satisfaction of Smartphone- and Smartwatch-Based Remote Active Testing and Passive Monitoring in People With Multiple Sclerosis: Nonrandomized Interventional Feasibility Study.
  Journal of medical Internet research 2019 Midaglia L, Mulero P, Montalban X, Graves J, Hauser SL, Julian L, Baker M, Schadrack J, Gossens C, Scotland A, Lipsmeier F, van Beek J, Bernasconi C, Belachew S, Lindemann M
• Opposing T cell responses in experimental autoimmune encephalomyelitis.
  Nature 2019 Saligrama N, Zhao F, Sikora MJ, Serratelli WS, Fernandes RA, Louis DM, Yao W, Ji X, Idoyaga J, Mahajan VB, Steinmetz LM, Chien YH, Hauser SL, Oksenberg JR, Garcia KC, Davis MM
• Reply to "Silent Progression or Bout Onset Progressive Multiple Sclerosis?"
  Annals of neurology 2019 Cree BAC, Hauser SL
• Sex-specific Tau methylation patterns and synaptic transcriptional alterations are associated with neural vulnerability during chronic neuroinflammation.
  Journal of autoimmunity 2019 Didonna A, Cantó E, Shams H, Isobe N, Zhao C, Caillier SJ, Condello C, Yamate-Morgan H, Tiwari-Woodruff SK, Mofrad MRK, Hauser SL, Oksenberg JR
• Nucleic Acid-Based Therapeutics Relevant to Neuroimmune Conditions.
  Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2019 Greenfield AL, Hauser SL
• Silent progression in disease activity-free relapsing multiple sclerosis.
  Annals of neurology 2019 University of California, San Francisco MS-EPIC Team, Cree BAC, Hollenbach JA, Bove R, Kirkish G, Sacco S, Caverzasi E, Bischof A, Gundel T, Zhu AH, Papinutto N, Stern WA, Bevan C, Romeo A, Goodin DS,…
• A specific amino acid motif of HLA-DRB1 mediates risk and interacts with smoking history in Parkinson's disease.
  Proceedings of the National Academy of Sciences of the United States of America 2019 Hollenbach JA, Norman PJ, Creary LE, Damotte V, Montero-Martin G, Caillier S, Anderson KM, Misra MK, Nemat-Gorgani N, Osoegawa K, Santaniello A, Renschen A, Marin WM, Dandekar R, Parham P, Tanner CM, …
• Longitudinally persistent cerebrospinal fluid B cells can resist treatment in multiple sclerosis.
  JCI insight 2019 Greenfield AL, Dandekar R, Ramesh A, Eggers EL, Wu H, Laurent S, Harkin W, Pierson NS, Weber MS, Henry RG, Bischof A, Cree BA, Hauser SL, Wilson MR, von Büdingen HC
• Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis.
  Journal of neurology 2019 Turner B, Cree BAC, Kappos L, Montalban X, Papeix C, Wolinsky JS, Buffels R, Fiore D, Garren H, Han J, Hauser SL
• B-Cell Therapies in Multiple Sclerosis.
  Cold Spring Harbor perspectives in medicine 2019 Sabatino JJ, Zamvil SS, Hauser SL
• Ocrelizumab infusion experience in patients with relapsing and primary progressive multiple sclerosis: Results from the phase 3 randomized OPERA I, OPERA II, and ORATORIO studies.
  Multiple sclerosis and related disorders 2019 Mayer L, Kappos L, Racke MK, Rammohan K, Traboulsee A, Hauser SL, Julian L, Köndgen H, Li C, Napieralski J, Zheng H, Wolinsky JS
• pRNFL as a marker of disability worsening in the medium/long term in patients with MS.
  Neurology(R) neuroimmunology & neuroinflammation 2018 Cordano C, Nourbakhsh B, Devereux M, Damotte V, Bennett D, Hauser SL, Cree BAC, Gelfand JM, Green AJ
• Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions.
  Multiple sclerosis (Houndmills, Basingstoke, England) 2018 Elliott C, Wolinsky JS, Hauser SL, Kappos L, Barkhof F, Bernasconi C, Wei W, Belachew S, Arnold DL
• Body mass index, but not vitamin D status, is associated with brain volume change in MS.
  Neurology 2018 Mowry EM, Azevedo CJ, McCulloch CE, Okuda DT, Lincoln RR, Waubant E, Hauser SL, Pelletier D
• Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial.
  Annals of neurology 2018 Wolinsky JS, Montalban X, Hauser SL, Giovannoni G, Vermersch P, Bernasconi C, Deol-Bhullar G, Garren H, Chin P, Belachew S, Kappos L
• Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosis.
  Multiple sclerosis (Houndmills, Basingstoke, England) 2018 Bove R, Bevan C, Crabtree E, Zhao C, Gomez R, Garcha P, Morrissey J, Dierkhising J, Green AJ, Hauser SL, Cree BA, Wallin MT, Gelfand JM
• Identification of MS-specific serum miRNAs in an international multicenter study.
  Neurology(R) neuroimmunology & neuroinflammation 2018 Regev K, Healy BC, Paul A, Diaz-Cruz C, Mazzola MA, Raheja R, Glanz BI, Kivisäkk P, Chitnis T, Jagodic M, Piehl F, Olsson T, Khademi M, Hauser S, Oksenberg J, Khoury SJ, Weiner HL, Gandhi R
• Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis.
  Annals of neurology 2018 Jia X, Madireddy L, Caillier S, Santaniello A, Esposito F, Comi G, Stuve O, Zhou Y, Taylor B, Kilpatrick T, Martinelli-Boneschi F, Cree BAC, Oksenberg JR, Hauser SL, Baranzini SE
• Multiple Sclerosis: B Cells Take Center Stage.
  Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2018 Pröbstel AK, Hauser SL
• Rituximab before and during pregnancy: A systematic review, and a case series in MS and NMOSD.
  Neurology(R) neuroimmunology & neuroinflammation 2018 Das G, Damotte V, Gelfand JM, Bevan C, Cree BAC, Do L, Green AJ, Hauser SL, Bove R
• No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a.
  Multiple sclerosis journal - experimental, translational and clinical 2018 Havrdová E, Arnold DL, Bar-Or A, Comi G, Hartung HP, Kappos L, Lublin F, Selmaj K, Traboulsee A, Belachew S, Bennett I, Buffels R, Garren H, Han J, Julian L, Napieralski J, Hauser SL, Giovannoni G
• Aberrant STAT phosphorylation signaling in peripheral blood mononuclear cells from multiple sclerosis patients.
  Journal of neuroinflammation 2018 Canto E, Isobe N, Didonna A, MS-EPIC Study Group, Hauser SL, Oksenberg JR
• Thalamic atrophy in multiple sclerosis: A magnetic resonance imaging marker of neurodegeneration throughout disease.
  Annals of neurology 2018 Azevedo CJ, Cen SY, Khadka S, Liu S, Kornak J, Shi Y, Zheng L, Hauser SL, Pelletier D
• Harnessing electronic medical records to advance research on multiple sclerosis.
  Multiple sclerosis (Houndmills, Basingstoke, England) 2018 Damotte V, Lizée A, Tremblay M, Agrawal A, Khankhanian P, Santaniello A, Gomez R, Lincoln R, Tang W, Chen T, Lee N, Villoslada P, Hollenbach JA, Bevan CD, Graves J, Bove R, Goodin DS, Green AJ, …
• B-cell Therapy for Multiple Sclerosis: Entering an era.
  Annals of neurology 2018 Greenfield AL, Hauser SL
• Ovarian aging is associated with gray matter volume and disability in women with MS.
  Neurology 2017 Graves JS, Henry RG, Cree BAC, Lambert-Messerlian G, Greenblatt RM, Waubant E, Cedars MI, Zhu A, University of California, San Francisco MS-EPIC Team,, Bacchetti P, Hauser SL, Oksenberg JR
• Diagnosing multiple sclerosis: art and science.
  The Lancet. Neurology 2017 Bove RM, Hauser SL
• Advances in Imaging Multiple Sclerosis.
  Seminars in neurology 2017 Bischof A, Caverzasi E, Cordano C, Hauser SL, Henry RG
• Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients.
  JCI insight 2017 Eggers EL, Michel BA, Wu H, Wang SZ, Bevan CJ, Abounasr A, Pierson NS, Bischof A, Kazer M, Leitner E, Greenfield AL, Demuth S, Wilson MR, Henry RG, Cree BA, Hauser SL, von Büdingen HC
• Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series.
  Neurology 2017 Gelfand JM, Bradshaw MJ, Stern BJ, Clifford DB, Wang Y, Cho TA, Koth LL, Hauser SL, Dierkhising J, Vu N, Sriram S, Moses H, Bagnato F, Kaufmann JA, Ammah DJ, Yohannes TH, Hamblin MJ, Venna N, Green AJ…
• Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial.
  Lancet (London, England) 2017 Green AJ, Gelfand JM, Cree BA, Bevan C, Boscardin WJ, Mei F, Inman J, Arnow S, Devereux M, Abounasr A, Nobuta H, Zhu A, Friessen M, Gerona R, von Büdingen HC, Henry RG, Hauser SL, Chan JR
• Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis.
  Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2017 Gelfand JM, Cree BAC, Hauser SL
• Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models.
  Proceedings of the National Academy of Sciences of the United States of America 2017 Cekanaviciute E, Yoo BB, Runia TF, Debelius JW, Singh S, Nelson CA, Kanner R, Bencosme Y, Lee YK, Hauser SL, Crabtree-Hartman E, Sand IK, Gacias M, Zhu Y, Casaccia P, Cree BAC, Knight R, Mazmanian SK,…
• SUMMIT (Serially Unified Multicenter Multiple Sclerosis Investigation): creating a repository of deeply phenotyped contemporary multiple sclerosis cohorts.
  Multiple sclerosis (Houndmills, Basingstoke, England) 2017 Bove R, Chitnis T, Cree BA, Tintoré M, Naegelin Y, Uitdehaag BM, Kappos L, Khoury SJ, Montalban X, Hauser SL, Weiner HL, SUMMIT Consortium
• Population Modeling Integrating Pharmacokinetics, Pharmacodynamics, Pharmacogenetics, and Clinical Outcome in Patients With Sunitinib-Treated Cancer.
  CPT: pharmacometrics & systems pharmacology 2017 Diekstra MH, Fritsch A, Kanefendt F, Swen JJ, Moes D, Sörgel F, Kinzig M, Stelzer C, Schindele D, Gauler T, Hauser S, Houtsma D, Roessler M, Moritz B, Mross K, Bergmann L, Oosterwijk E, Kiemeney LA, …
• STAT [editorial]
  3 ways the VA can usher in the future of health care and research. 2017 Hauser SL, VanLeeuwen J-E.
• [When is surgical resection of the primary tumor indicated in metastatic urothelial carcinoma of the bladder and what is the scientific rationale?]
  Der Urologe. Ausg. A 2017 Ellinger J, Hauser S, Kübler H, Müller SC
• Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis.
  The New England journal of medicine 2017 Hauser SL, Belachew S, Kappos L
• Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
  The New England journal of medicine 2016 Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew…
• Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
  The New England journal of medicine 2016 Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, Masterman D, Fontoura P, Belachew…
• Onset of secondary progressive MS after long-term rituximab therapy - a case report.
  Annals of clinical and translational neurology 2016 von Büdingen HC, Bischof A, Eggers EL, Wang S, Bevan CJ, Cree BA, Henry RG, Hauser SL
• Long-term evolution of multiple sclerosis disability in the treatment era.
  Annals of neurology 2016 University of California, San Francisco MS-EPIC Team:, Cree BA, Gourraud PA, Oksenberg JR, Bevan C, Crabtree-Hartman E, Gelfand JM, Goodin DS, Graves J, Green AJ, Mowry E, Okuda DT, Pelletier D, von …
• Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies.
  Neurology. Genetics 2016 George MF, Briggs FB, Shao X, Gianfrancesco MA, Kockum I, Harbo HF, Celius EG, Bos SD, Hedström A, Shen L, Bernstein A, Alfredsson L, Hillert J, Olsson T, Patsopoulos NA, De Jager PL, Oturai AB, …
• Association of HLA Genetic Risk Burden With Disease Phenotypes in Multiple Sclerosis.
  JAMA neurology 2016 Isobe N, Keshavan A, Gourraud PA, Zhu AH, Datta E, Schlaeger R, Caillier SJ, Santaniello A, Lizée A, Himmelstein DS, Baranzini SE, Hollenbach J, Cree BA, Hauser SL, Oksenberg JR, Henry RG
• An important role for Myb-MuvB and its target gene KIF23 in a mouse model of lung adenocarcinoma.
  Oncogene 2016 Iltzsche F, Simon K, Stopp S, Pattschull G, Francke S, Wolter P, Hauser S, Murphy DJ, Garcia P, Rosenwald A, Gaubatz S
• Power estimation for non-standardized multisite studies.
  NeuroImage 2016 Keshavan A, Paul F, Beyer MK, Zhu AH, Papinutto N, Shinohara RT, Stern W, Amann M, Bakshi R, Bischof A, Carriero A, Comabella M, Crane JC, D'Alfonso S, Demaerel P, Dubois B, Filippi M, Fleischer V, …
• Meta-analysis of genome-wide association studies reveals genetic overlap between Hodgkin lymphoma and multiple sclerosis.
  International journal of epidemiology 2016 Khankhanian P, Cozen W, Himmelstein DS, Madireddy L, Din L, van den Berg A, Matsushita T, Glaser SL, Moré JM, Smedby KE, Baranzini SE, Mack TM, Lizée A, de Sanjosé S, Gourraud PA, Nieters A, Hauser SL…
• A non-synonymous single-nucleotide polymorphism associated with multiple sclerosis risk affects the EVI5 interactome.
  Human molecular genetics 2015 Didonna A, Isobe N, Caillier SJ, Li KH, Burlingame AL, Hauser SL, Baranzini SE, Patsopoulos NA, Oksenberg JR
• Class II HLA interactions modulate genetic risk for multiple sclerosis.
  Nature genetics 2015 Moutsianas L, Jostins L, Beecham AH, Dilthey AT, Xifara DK, Ban M, Shah TS, Patsopoulos NA, Alfredsson L, Anderson CA, Attfield KE, Baranzini SE, Barrett J, Binder TMC, Booth D, Buck D, Celius EG, …
• Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.
  JAMA neurology 2015 Schlaeger R, Papinutto N, Zhu AH, Lobach IV, Bevan CJ, Bucci M, Castellano A, Gelfand JM, Graves JS, Green AJ, Jordan KM, Keshavan A, Panara V, Stern WA, von Büdingen HC, Waubant E, Goodin DS, Cree BA…
• Genetic contribution to multiple sclerosis risk among Ashkenazi Jews.
  BMC medical genetics 2015 Khankhanian P, Matsushita T, Madireddy L, Lizée A, Din L, Moré JM, Gourraud PA, Hauser SL, Baranzini SE, Oksenberg JR
• Mitochondrial DNA sequence variation in multiple sclerosis.
  Neurology 2015 Tranah GJ, Santaniello A, Caillier SJ, D'Alfonso S, Martinelli Boneschi F, Hauser SL, Oksenberg JR
• Advancing ethical neuroscience.
  Annals of neurology 2015 Hauser SL
• Percutaneous CT-Guided Radiofrequency Ablation of Solitary Small Renal Masses: A Single Center Experience.
  RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin 2015 Pieper CC, Fischer S, Strunk H, Meyer C, Thomas D, Willinek WA, Hauser S, Nadal J, Schild H, Wilhelm K
• An ImmunoChip study of multiple sclerosis risk in African Americans.
  Brain : a journal of neurology 2015 Isobe N, Madireddy L, Khankhanian P, Matsushita T, Caillier SJ, Moré JM, Gourraud PA, McCauley JL, Beecham AH, International Multiple Sclerosis Genetics Consortium, Piccio L, Herbert J, Khan O, Cohen …
• Age, gender and normalization covariates for spinal cord gray matter and total cross-sectional areas at cervical and thoracic levels: A 2D phase sensitive inversion recovery imaging study.
  PloS one 2015 Papinutto N, Schlaeger R, Panara V, Zhu AH, Caverzasi E, Stern WA, Hauser SL, Henry RG
• Genetic associations with brain cortical thickness in multiple sclerosis.
  Genes, brain, and behavior 2015 Matsushita T, Madireddy L, Sprenger T, Khankhanian P, Magon S, Naegelin Y, Caverzasi E, Lindberg RL, Kappos L, Hauser SL, Oksenberg JR, Henry R, Pelletier D, Baranzini SE
• Hematopoietic stem cell transplantation for MS: extraordinary evidence still needed.
  JAMA 2015 Hauser SL
• High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis.
  Nature genetics 2015 Goyette P, Boucher G, Mallon D, Ellinghaus E, Jostins L, Huang H, Ripke S, Gusareva ES, Annese V, Hauser SL, Oksenberg JR, Thomsen I, Leslie S, International Inflammatory Bowel Disease Genetics …
• 2D phase-sensitive inversion recovery imaging to measure in vivo spinal cord gray and white matter areas in clinically feasible acquisition times.
  Journal of magnetic resonance imaging : JMRI 2014 Papinutto N, Schlaeger R, Panara V, Caverzasi E, Ahn S, Johnson KJ, Zhu AH, Stern WA, Laub G, Hauser SL, Henry RG
• The Charcot Lecture | beating MS: a story of B cells, with twists and turns.
  Multiple sclerosis (Houndmills, Basingstoke, England) 2014 Hauser SL
• Precision medicine in chronic disease management: The multiple sclerosis BioScreen.
  Annals of neurology 2014 Gourraud PA, Henry RG, Cree BA, Crane JC, Lizee A, Olson MP, Santaniello AV, Datta E, Zhu AH, Bevan CJ, Gelfand JM, Graves JS, Goodin DS, Green AJ, von Büdingen HC, Waubant E, Zamvil SS, Crabtree-…
• Spinal cord gray matter atrophy correlates with multiple sclerosis disability.
  Annals of neurology 2014 Schlaeger R, Papinutto N, Panara V, Bevan C, Lobach IV, Bucci M, Caverzasi E, Gelfand JM, Green AJ, Jordan KM, Stern WA, von Büdingen HC, Waubant E, Zhu AH, Goodin DS, Cree BA, Hauser SL, Henry RG
• Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis.
  Science translational medicine 2014 Palanichamy A, Apeltsin L, Kuo TC, Sirota M, Wang S, Pitts SJ, Sundar PD, Telman D, Zhao LZ, Derstine M, Abounasr A, Hauser SL, von Büdingen HC
• In vivo evidence of glutamate toxicity in multiple sclerosis.
  Annals of neurology 2014 Azevedo CJ, Kornak J, Chu P, Sampat M, Okuda DT, Cree BA, Nelson SJ, Hauser SL, Pelletier D
• Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis.
  Nature medicine 2014 Mei F, Fancy SPJ, Shen YA, Niu J, Zhao C, Presley B, Miao E, Lee S, Mayoral SR, Redmond SA, Etxeberria A, Xiao L, Franklin RJM, Green A, Hauser SL, Chan JR
• HLA diversity in the 1000 genomes dataset.
  PloS one 2014 Gourraud PA, Khankhanian P, Cereb N, Yang SY, Feolo M, Maiers M, Rioux JD, Hauser S, Oksenberg J
• Magnetic resonance spectroscopy markers of disease progression in multiple sclerosis.
  JAMA neurology 2014 Llufriu S, Kornak J, Ratiney H, Oh J, Brenneman D, Cree BA, Sampat M, Hauser SL, Nelson SJ, Pelletier D
• Rituximab efficiently depletes increased CD20-expressing T cells in multiple sclerosis patients.
  Journal of immunology (Baltimore, Md. : 1950) 2014 Palanichamy A, Jahn S, Nickles D, Derstine M, Abounasr A, Hauser SL, Baranzini SE, Leppert D, von Büdingen HC
• What ethics integration looks like in neuroscience research.
  Annals of neurology 2014 Hauser SL
• MHC associations with clinical and autoantibody manifestations in European SLE.
  Genes and immunity 2014 Morris DL, Fernando MM, Taylor KE, Chung SA, Nititham J, Alarcón-Riquelme ME, Barcellos LF, Behrens TW, Cotsapas C, Gaffney PM, Graham RR, Pons-Estel BA, Gregersen PK, Harley JB, Hauser SL, Hom G, …
• In multiple sclerosis, oligoclonal bands connect to peripheral B-cell responses.
  Annals of neurology 2014 Bankoti J, Apeltsin L, Hauser SL, Allen S, Albertolle ME, Witkowska HE, von Büdingen HC
• Quo vadis? Peering into the future.
  Annals of neurology 2013 Hauser SL, Johnston SC, Ferriero DM, Josephson SA, Lowenstein DH, Messing RO, Oksenberg JR
• Have the Annals editors added value?
  Annals of neurology 2013 Johnston SC, Ferriero DM, Josephson SA, Lowenstein DH, Messing RO, Oksenberg J, Stewart A, Hauser SL
• Oligoclonal bands and age at onset correlate with genetic risk score in multiple sclerosis.
  Multiple sclerosis (Houndmills, Basingstoke, England) 2013 Harbo HF, Isobe N, Berg-Hansen P, Bos SD, Caillier SJ, Gustavsen MW, Mero IL, Celius EG, Hauser SL, Oksenberg JR, Gourraud PA
• Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
  Nature genetics 2013 International Multiple Sclerosis Genetics Consortium (IMSGC), Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, Kemppinen A, Cotsapas C, Shah TS, Spencer C, Booth D, Goris A, Oturai A, Saarela J, …
• Blockbusters for cheap? The difficulties surrounding generic biologics.
  Annals of neurology 2013 Josephson SA, Johnston SC, Hauser SL
• Introduction to a special edition of Annals: Therapeutic prospects.
  Annals of neurology 2013 Brown RH, Hauser SL
• Multiple sclerosis: Prospects and promise.
  Annals of neurology 2013 Hauser SL, Chan JR, Oksenberg JR
• Genetic burden in multiple sclerosis families.
  Genes and immunity 2013 Isobe N, Damotte V, Re VL, Ban M, Pappas D, Guillot-Noel L, Rebeix I, Compston A, Mack T, Cozen W, Fontaine B, Hauser SL, Oksenberg JR, Sawcer S, Gourraud PA
• Neurology: violence at home.
  Annals of neurology 2013 Hauser SL, Johnston SC
• Living in the time of sequestration.
  Annals of neurology 2013 Hauser SL, Johnston SC
• Tob1 plays a critical role in the activation of encephalitogenic T cells in CNS autoimmunity.
  The Journal of experimental medicine 2013 Schulze-Topphoff U, Casazza S, Varrin-Doyer M, Pekarek K, Sobel RA, Hauser SL, Oksenberg JR, Zamvil SS, Baranzini SE
• Genetic risk variants in African Americans with multiple sclerosis.
  Neurology 2013 Isobe N, Gourraud PA, Harbo HF, Caillier SJ, Santaniello A, Khankhanian P, Maiers M, Spellman S, Cereb N, Yang S, Pando MJ, Piccio L, Cross AH, De Jager PL, Cree BA, Hauser SL, Oksenberg JR
• Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls.
  Human molecular genetics 2013 Nickles D, Chen HP, Li MM, Khankhanian P, Madireddy L, Caillier SJ, Santaniello A, Cree BA, Pelletier D, Hauser SL, Oksenberg JR, Baranzini SE
• The dangers of clinical conviction: an "M&M" of endovascular therapies for stroke.
  Annals of neurology 2013 Johnston SC, Hauser SL
• The neurologic revolving door: time to pay attention to readmissions.
  Annals of neurology 2013 Josephson SA, Johnston SC, Hauser SL
• Big neuroscience.
  Annals of neurology 2013 Hauser SL, Johnston SC
• Multiple sclerosis: monotherapy rules.
  Annals of neurology 2013 Hauser SL, Josephson SA, Johnston SC
• No evidence of association between mutant alleles of the CYP27B1 gene and multiple sclerosis.
  Annals of neurology 2013 Ban M, Caillier S, Mero IL, Myhr KM, Celius EG, Aarseth J, Torkildsen Ø, Harbo HF, Oksenberg J, Hauser SL, Sawcer S, Compston A
• A genome-wide association study of brain lesion distribution in multiple sclerosis.
  Brain : a journal of neurology 2013 Gourraud PA, Sdika M, Khankhanian P, Henry RG, Beheshtian A, Matthews PM, Hauser SL, Oksenberg JR, Pelletier D, Baranzini SE
• Are relative value units hurting healthcare?
  Annals of neurology 2013 Johnston SC, Josephson SA, Hauser SL
• DSM-V: psychodrama on the public stage.
  Annals of neurology 2013 Hauser SL, Johnston SC
• Reply to Dr Sethi.
  Annals of neurology 2013 Hauser SL
• Copy number variation in pediatric multiple sclerosis.
  Multiple sclerosis (Houndmills, Basingstoke, England) 2012 McElroy JP, Krupp LB, Johnson BA, McCauley JL, Qi Z, Caillier SJ, Gourraud PA, Yu J, Nathanson L, Belman AL, Hauser SL, Waubant E, Hedges DJ, Oksenberg JR
• Electronic medical records and the academic neurologist: when carrots turn into sticks.
  Annals of neurology 2012 Josephson SA, Johnston SC, Hauser SL
• B cell exchange across the blood-brain barrier in multiple sclerosis.
  The Journal of clinical investigation 2012 von Büdingen HC, Kuo TC, Sirota M, van Belle CJ, Apeltsin L, Glanville J, Cree BA, Gourraud PA, Schwartzburg A, Huerta G, Telman D, Sundar PD, Casey T, Cox DR, Hauser SL
• Deciphering the signature injury.
  Annals of neurology 2012 Hauser SL, Josephson SA, Johnston SC
• [Educating transurethral electroresection of the prostate is safe and efficient: is training a risk factor for patients and hospitals?].
  Der Urologe. Ausg. A 2012 Fechner G, Schaupp J, Hauser S, Müller SC
• Unraveling multiple MHC gene associations with systemic lupus erythematosus: model choice indicates a role for HLA alleles and non-HLA genes in Europeans.
  American journal of human genetics 2012 Morris DL, Taylor KE, Fernando MM, Nititham J, Alarcón-Riquelme ME, Barcellos LF, Behrens TW, Cotsapas C, Gaffney PM, Graham RR, Pons-Estel BA, Gregersen PK, Harley JB, Hauser SL, Hom G, International…
• Healthcare costs: Eden's apple?
  Annals of neurology 2012 Johnston SC, Hauser SL
• In depth comparison of an individual's DNA and its lymphoblastoid cell line using whole genome sequencing.
  BMC genomics 2012 Nickles D, Madireddy L, Yang S, Khankhanian P, Lincoln S, Hauser SL, Oksenberg JR, Baranzini SE
• Beaten into action: a perspective on blood sports.
  Annals of neurology 2012 Hauser SL
• Note to aspiring clinician scientists: skies are clearing.
  Annals of neurology 2012 Hauser SL
• Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis.
  Annals of neurology 2012 Mowry EM, Waubant E, McCulloch CE, Okuda DT, Evangelista AA, Lincoln RR, Gourraud PA, Brenneman D, Owen MC, Qualley P, Bucci M, Hauser SL, Pelletier D
• The genetics of multiple sclerosis: an up-to-date review.
  Immunological reviews 2012 Gourraud PA, Harbo HF, Hauser SL, Baranzini SE
• Florbetapir: knowing one's future.
  Annals of neurology 2012 Hauser SL, Josephson SA, Johnston SC
• Multiple sclerosis drugs: sticker shock.
  Annals of neurology 2012 Hauser SL, Johnston SC
• Evidence of novel fine-scale structural variation at autism spectrum disorder candidate loci.
  Molecular autism 2012 Hedges DJ, Hamilton-Nelson KL, Sacharow SJ, Nations L, Beecham GW, Kozhekbaeva ZM, Butler BL, Cukier HN, Whitehead PL, Ma D, Jaworski JM, Nathanson L, Lee JM, Hauser SL, Oksenberg JR, Cuccaro ML, …
• The neurological exam: striking a nerve.
  Annals of neurology 2012 Johnston SC, Hauser SL
• Modern care for neurological problems must address waste.
  Annals of neurology 2012 Johnston SC, Hauser SL
• Color vision is strongly associated with retinal thinning in multiple sclerosis.
  Multiple sclerosis (Houndmills, Basingstoke, England) 2012 Villoslada P, Cuneo A, Gelfand J, Hauser SL, Green A
• Fighting decision fatigue.
  Annals of neurology 2012 Stewart AF, Ferriero DM, Josephson SA, Lowenstein DH, Messing RO, Oksenberg JR, Johnston SC, Hauser SL
• Decoding multiple sclerosis.
  Annals of neurology 2011 Oksenberg JR, Hauser SL
• Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci.
  Annals of neurology 2011 Patsopoulos NA, Bayer Pharma MS Genetics Working Group, Steering Committees of Studies Evaluating IFNß-1b and a CCR1-Antagonist, ANZgene Consortium, GeneMSA, International Multiple Sclerosis Genetics …
• Naive antibody gene-segment frequencies are heritable and unaltered by chronic lymphocyte ablation.
  Proceedings of the National Academy of Sciences of the United States of America 2011 Glanville J, Kuo TC, von Büdingen HC, Guey L, Berka J, Sundar PD, Huerta G, Mehta GR, Oksenberg JR, Hauser SL, Cox DR, Rajpal A, Pons J
• Benefits of medical research: Hollywood weighs in.
  Annals of neurology 2011 Hauser SL, Johnston SC
• Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial.
  Lancet (London, England) 2011 Kappos L, Li D, Calabresi PA, O'Connor P, Bar-Or A, Barkhof F, Yin M, Leppert D, Glanzman R, Tinbergen J, Hauser SL
• Global clinical trials: challenges ahead.
  Annals of neurology 2011 Hauser SL, Johnston SC
• Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.
  Journal of the National Cancer Institute 2011 Curran WJ, Paulus R, Langer CJ, Komaki R, Lee JS, Hauser S, Movsas B, Wasserman T, Rosenthal SA, Gore E, Machtay M, Sause W, Cox JD
• Waking up to narcolepsy.
  Annals of neurology 2011 Hauser SL, Johnston SC
• Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.
  Nature 2011 International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium 2, Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L, Dilthey A, Su Z, Freeman C,…
• Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring.
  The Lancet. Neurology 2011 Kappos L, Bates D, Edan G, Eraksoy M, Garcia-Merino A, Grigoriadis N, Hartung HP, Havrdová E, Hillert J, Hohlfeld R, Kremenchutzky M, Lyon-Caen O, Miller A, Pozzilli C, Ravnborg M, Saida T, Sindic C, …
• The beautiful and ethereal neurological exam: an appeal for research.
  Annals of neurology 2011 Johnston SC, Hauser SL
• SNP-based analysis of the HLA locus in Japanese multiple sclerosis patients.
  Genes and immunity 2011 McElroy JP, Isobe N, Gourraud PA, Caillier SJ, Matsushita T, Kohriyama T, Miyamoto K, Nakatsuji Y, Miki T, Hauser SL, Oksenberg JR, Kira J
• Interrogating the complex role of chromosome 16p13.13 in multiple sclerosis susceptibility: independent genetic signals in the CIITA-CLEC16A-SOCS1 gene complex.
  Human molecular genetics 2011 Zuvich RL, Bush WS, McCauley JL, Beecham AH, De Jager PL, International Multiple Sclerosis Genetics Consortium, Ivinson AJ, Compston A, Hafler DA, Hauser SL, Sawcer SJ, Pericak-Vance MA, Barcellos LF,…
• Vitamin D in African Americans with multiple sclerosis.
  Neurology 2011 Gelfand JM, Cree BA, McElroy J, Oksenberg J, Green R, Mowry EM, Miller JW, Hauser SL, Green AJ
• Grey matter volume in a large cohort of MS patients: relation to MRI parameters and disability.
  Multiple sclerosis (Houndmills, Basingstoke, England) 2011 Roosendaal SD, Bendfeldt K, Vrenken H, Polman CH, Borgwardt S, Radue EW, Kappos L, Pelletier D, Hauser SL, Matthews PM, Barkhof F, Geurts JJ
• The NIH shuffle, NCATS, and neurology.
  Annals of neurology 2011 Johnston SC, Hauser SL
• Enhancing ties between academia and industry to improve health.
  Nature medicine 2011 Johnston SC, Hauser SL, Desmond-Hellmann S
• Extraordinary claims require extraordinary evidence.
  Annals of neurology 2011 Hauser SL, Johnston SC
• Scientific literacy and the media.
  Annals of neurology 2011 Hauser SL, Johnston SC
• A knowledge-driven interaction analysis reveals potential neurodegenerative mechanism of multiple sclerosis susceptibility.
  Genes and immunity 2011 Bush WS, McCauley JL, DeJager PL, Dudek SM, Hafler DA, Gibson RA, Matthews PM, Kappos L, Naegelin Y, Polman CH, Hauser SL, Oksenberg J, Haines JL, Ritchie MD, International Multiple Sclerosis Genetics…
• Modeling the cumulative genetic risk for multiple sclerosis from genome-wide association data.
  Genome medicine 2011 Wang JH, Pappas D, De Jager PL, Pelletier D, de Bakker PI, Kappos L, Polman CH, Australian and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene), Chibnik LB, Hafler DA, Matthews PM, Hauser …
• Aggregation of multiple sclerosis genetic risk variants in multiple and single case families.
  Annals of neurology 2011 Gourraud PA, McElroy JP, Caillier SJ, Johnson BA, Santaniello A, Hauser SL, Oksenberg JR
• Neurologic education 2011: new challenges and opportunities.
  Annals of neurology 2010 Josephson SA, Hauser SL
• Genetic variation in the odorant receptors family 13 and the mhc loci influence mate selection in a multiple sclerosis dataset.
  BMC genomics 2010 Khankhanian P, Gourraud PA, Caillier SJ, Santaniello A, Hauser SL, Baranzini SE, Oksenberg JR
• Malignant middle cerebral artery stroke: Where ischemia meets the scalpel.
  Annals of neurology 2010 Josephson SA, Hauser SL, Johnston SC
• Fred Plum (1924-2010) and the founding of the Annals of Neurology.
  Annals of neurology 2010 Hauser SL, Johnston SC
• Genetic variation influences glutamate concentrations in brains of patients with multiple sclerosis.
  Brain : a journal of neurology 2010 Baranzini SE, Srinivasan R, Khankhanian P, Okuda DT, Nelson SJ, Matthews PM, Hauser SL, Oksenberg JR, Pelletier D
• Evidence for CRHR1 in multiple sclerosis using supervised machine learning and meta-analysis in 12,566 individuals.
  Human molecular genetics 2010 Briggs FB, Bartlett SE, Goldstein BA, Wang J, McCauley JL, Zuvich RL, De Jager PL, Rioux JD, Ivinson AJ, Compston A, Hafler DA, Hauser SL, Oksenberg JR, Sawcer SJ, Pericak-Vance MA, Haines JL, …
• The challenge of publishing newsworthy epidemiology.
  Annals of neurology 2010 Johnston SC, Hauser SL
• 4-aminopyridine: new life for an old drug.
  Annals of neurology 2010 Hauser SL, Johnston SC
• A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.
  PloS one 2010 Cree BA, Rioux JD, McCauley JL, Gourraud PA, Goyette P, McElroy J, De Jager P, Santaniello A, Vyse TJ, Gregersen PK, Mirel D, Hafler DA, Haines JL, Pericak-Vance MA, Compston A, Sawcer SJ, Oksenberg …
• A non-synonymous SNP within membrane metalloendopeptidase-like 1 (MMEL1) is associated with multiple sclerosis.
  Genes and immunity 2010 Ban M, McCauley JL, Zuvich R, Baker A, Bergamaschi L, Cox M, Kemppinen A, D'Alfonso S, Guerini FR, Lechner-Scott J, Dudbridge F, Wason J, Robertson NP, De Jager PL, Hafler DA, Barcellos LF, Ivinson AJ…
• Comparison of inguinal approach, scrotal sclerotherapy and subinguinal antegrade sclerotherapy in varicocele treatment: a randomized prospective study.
  Urologia internationalis 2010 Fayez A, El Shantaly KM, Abbas M, Hauser S, Müller SC, Fathy A
• Variation within DNA repair pathway genes and risk of multiple sclerosis.
  American journal of epidemiology 2010 Briggs FB, Goldstein BA, McCauley JL, Zuvich RL, De Jager PL, Rioux JD, Ivinson AJ, Compston A, Hafler DA, Hauser SL, Oksenberg JR, Sawcer SJ, Pericak-Vance MA, Haines JL, Barcellos LF, International …
• Lack of support for association between the KIF1B rs10492972[C] variant and multiple sclerosis.
  Nature genetics 2010 International Multiple Sclerosis Genetics Consortium (IMSGC), Booth DR, Heard RN, Stewart GJ, Cox M, Scott RJ, Lechner-Scott J, Goris A, Dobosi R, Dubois B, Saarela J, Leppä V, Peltonen L, Pirttila T,…
• Mapping the human genome with newfound precision.
  Annals of neurology 2010 Oksenberg JR, Hauser SL
• [Urethral reconstructive surgery].
  Der Urologe. Ausg. A 2010 Hauser S, Fechner G, Ellinger J, Müller SC
• Refining the association of MHC with multiple sclerosis in African Americans.
  Human molecular genetics 2010 McElroy JP, Cree BA, Caillier SJ, Gregersen PK, Herbert J, Khan OA, Freudenberg J, Lee A, Bridges SL, Hauser SL, Oksenberg JR, Gourraud PA
• Supply does not satisfy demand in child neurology.
  Annals of neurology 2010 Ferriero DM, Hauser SL
• Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis.
  Nature 2010 Baranzini SE, Mudge J, van Velkinburgh JC, Khankhanian P, Khrebtukova I, Miller NA, Zhang L, Farmer AD, Bell CJ, Kim RW, May GD, Woodward JE, Caillier SJ, McElroy JP, Gomez R, Pando MJ, Clendenen LE, …
• Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration.
  Brain : a journal of neurology 2010 Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R
• Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
  Annals of neurology 2010 Bar-Or A, Fawaz L, Fan B, Darlington PJ, Rieger A, Ghorayeb C, Calabresi PA, Waubant E, Hauser SL, Zhang J, Smith CH
• Neuroreconciliation and the health care debate.
  Annals of neurology 2010 Hauser SL, Johnston SC, Stewart AF
• CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis.
  Human molecular genetics 2010 Bronson PG, Caillier S, Ramsay PP, McCauley JL, Zuvich RL, De Jager PL, Rioux JD, Ivinson AJ, Compston A, Hafler DA, Sawcer SJ, Pericak-Vance MA, Haines JL, International Multiple Sclerosis Genetics …
• Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene.
  American journal of human genetics 2010 Jakkula E, Leppä V, Sulonen AM, Varilo T, Kallio S, Kemppinen A, Purcell S, Koivisto K, Tienari P, Sumelahti ML, Elovaara I, Pirttilä T, Reunanen M, Aromaa A, Oturai AB, Søndergaard HB, Harbo HF, Mero…
• Getting youth in the game: can we accelerate training for clinician-scientists?
  Annals of neurology 2010 Hauser SL, Lowenstein DH, Johnston SC
• Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility.
  Human genetics 2010 Zuvich RL, McCauley JL, Oksenberg JR, Sawcer SJ, De Jager PL, International Multiple Sclerosis Genetics Consortium, Aubin C, Cross AH, Piccio L, Aggarwal NT, Evans D, Hafler DA, Compston A, Hauser SL,…
• Ureterocystoplasty: an ideal method for vesical augmentation in children.
  Aktuelle Urologie 2010 Fisang C, Hauser S, Müller SC
• Status report: the Annals in 2010.
  Annals of neurology 2010 Hauser SL, Johnston SC, Ferriero DM, Lowenstein DH, Josephson SA, Messing RO, Oksenberg JR, Stewart AF
• Genome-wide patterns of population structure and admixture in West Africans and African Americans.
  Proceedings of the National Academy of Sciences of the United States of America 2009 Bryc K, Auton A, Nelson MR, Oksenberg JR, Hauser SL, Williams S, Froment A, Bodo JM, Wambebe C, Tishkoff SA, Bustamante CD
• Research trainees in the clinical neurosciences: still a shallow pool.
  Annals of neurology 2009 Hauser SL, Johnston SC
• IOM task impossible: set the agenda for neurological comparative effectiveness research.
  Annals of neurology 2009 Johnston SC, Hauser SL
• Modified spectrometry (O2C device) of intraoperative microperfusion predicts organ function after kidney transplantation: a pilot study.
  Transplantation proceedings 2009 Fechner G, von Pezold J, Luzar O, Hauser S, Tolba RH, Müller SC
• Multiple sclerosis susceptibility alleles in African Americans.
  Genes and immunity 2009 Johnson BA, Wang J, Taylor EM, Caillier SJ, Herbert J, Khan OA, Cross AH, De Jager PL, Gourraud PA, Cree BC, Hauser SL, Oksenberg JR
• Mapping of multiple susceptibility variants within the MHC region for 7 immune-mediated diseases.
  Proceedings of the National Academy of Sciences of the United States of America 2009 International MHC and Autoimmunity Genetics Network, Rioux JD, Goyette P, Vyse TJ, Hammarström L, Fernando MM, Green T, De Jager PL, Foisy S, Wang J, de Bakker PI, Leslie S, McVean G, Padyukov L, …
• Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial.
  Annals of neurology 2009 Hawker K, O'Connor P, Freedman MS, Calabresi PA, Antel J, Simon J, Hauser S, Waubant E, Vollmer T, Panitch H, Zhang J, Chin P, Smith CH, OLYMPUS trial group
• Balancing risk and reward: the question of natalizumab.
  Annals of neurology 2009 Hauser SL, Johnston SC
• Disparities in care: guilty until proven innocent.
  Annals of neurology 2009 Johnston SC, Hauser SL
• Follow-up examination of linkage and association to chromosome 1q43 in multiple sclerosis.
  Genes and immunity 2009 McCauley JL, Zuvich RL, Bradford Y, Kenealy SJ, Schnetz-Boutaud N, Gregory SG, Hauser SL, Oksenberg JR, Mortlock DP, Pericak-Vance MA, Haines JL
• Journeys in complex genetics: music and mental illness.
  Annals of neurology 2009 Hauser SL, Johnston SC
• Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci.
  Nature genetics 2009 De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, Aggarwal NT, Piccio L, Raychaudhuri S, Tran D, Aubin C, Briskin R, Romano S, International MS Genetics Consortium, Baranzini SE, McCauley JL, …
• Crowdsourcing scientific innovation.
  Annals of neurology 2009 Johnston SC, Hauser SL
• Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures.
  Neurology 2009 Mowry EM, Beheshtian A, Waubant E, Goodin DS, Cree BA, Qualley P, Lincoln R, George MF, Gomez R, Hauser SL, Okuda DT, Pelletier D
• Message from the editor: on humility.
  Annals of neurology 2009 Hauser SL, Stewart AF, Johnston SC
• Economic over-stimulation?
  Annals of neurology 2009 Johnston SC, Hauser SL
• Replication analysis identifies TYK2 as a multiple sclerosis susceptibility factor.
  European journal of human genetics : EJHG 2009 Ban M, Goris A, Lorentzen AR, Baker A, Mihalova T, Ingram G, Booth DR, Heard RN, Stewart GJ, Bogaert E, Dubois B, Harbo HF, Celius EG, Spurkland A, Strange R, Hawkins C, Robertson NP, Dudbridge F, …
• Pathway and network-based analysis of genome-wide association studies in multiple sclerosis.
  Human molecular genetics 2009 Baranzini SE, Galwey NW, Wang J, Khankhanian P, Lindberg R, Pelletier D, Wu W, Uitdehaag BM, Kappos L, GeneMSA Consortium, Polman CH, Matthews PM, Hauser SL, Gibson RA, Oksenberg JR, Barnes MR
• Personalized genetic scans: with gifts like these...
  Annals of neurology 2009 Hauser SL, Johnston SC
• The role of the CD58 locus in multiple sclerosis.
  Proceedings of the National Academy of Sciences of the United States of America 2009 De Jager PL, Baecher-Allan C, Maier LM, Arthur AT, Ottoboni L, Barcellos L, McCauley JL, Sawcer S, Goris A, Saarela J, Yelensky R, Price A, Leppa V, Patterson N, de Bakker PI, Tran D, Aubin C, …
• Comparative effectiveness research in the neurosciences.
  Annals of neurology 2009 Johnston SC, Hauser SL
• Modification of Multiple Sclerosis Phenotypes by African Ancestry at HLA.
  Archives of neurology 2009 Cree BA, Reich DE, Khan O, De Jager PL, Nakashima I, Takahashi T, Bar-Or A, Tong C, Hauser SL, Oksenberg JR
• IL2RA genetic heterogeneity in multiple sclerosis and type 1 diabetes susceptibility and soluble interleukin-2 receptor production.
  PLoS genetics 2009 Maier LM, Lowe CE, Cooper J, Downes K, Anderson DE, Severson C, Clark PM, Healy B, Walker N, Aubin C, Oksenberg JR, Hauser SL, Compston A, Sawcer S, International Multiple Sclerosis Genetics …
• Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome.
  Neurology 2008 Okuda DT, Mowry EM, Beheshtian A, Waubant E, Baranzini SE, Goodin DS, Hauser SL, Pelletier D
• Translational research for a new administration: what sort of change to believe in?
  Annals of neurology 2008 Hauser SL, Johnston SC
• Genotype-Phenotype correlations in multiple sclerosis: HLA genes influence disease severity inferred by 1HMR spectroscopy and MRI measures.
  Brain : a journal of neurology 2008 Okuda DT, Srinivasan R, Oksenberg JR, Goodin DS, Baranzini SE, Beheshtian A, Waubant E, Zamvil SS, Leppert D, Qualley P, Lincoln R, Gomez R, Caillier S, George M, Wang J, Nelson SJ, Cree BA, Hauser SL…
• Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis.
  Human molecular genetics 2008 Baranzini SE, Wang J, Gibson RA, Galwey N, Naegelin Y, Barkhof F, Radue EW, Lindberg RL, Uitdehaag BM, Johnson MR, Angelakopoulou A, Hall L, Richardson JC, Prinjha RK, Gass A, Geurts JJ, Kragt J, …
• Peer review at National Institutes of Health: small steps forward.
  Annals of neurology 2008 Johnston SC, Hauser SL
• Multiple lessons for multiple sclerosis.
  The New England journal of medicine 2008 Hauser SL
• Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis.
  Journal of immunology (Baltimore, Md. : 1950) 2008 Caillier SJ, Briggs F, Cree BA, Baranzini SE, Fernandez-Viña M, Ramsay PP, Khan O, Royal W, Hauser SL, Barcellos LF, Oksenberg JR
• Scripts for science: a new wrinkle on academic ties with industry.
  Annals of neurology 2008 Hauser SL, Johnston SC
• Investigator balkanization.
  Annals of neurology 2008 Johnston SC, Hauser SL
• The Population Reference Sample, POPRES: a resource for population, disease, and pharmacological genetics research.
  American journal of human genetics 2008 Nelson MR, Bryc K, King KS, Indap A, Boyko AR, Novembre J, Briley LP, Maruyama Y, Waterworth DM, Waeber G, Vollenweider P, Oksenberg JR, Hauser SL, Stirnadel HA, Kooner JS, Chambers JC, Jones B, …
• Abrogation of T cell quiescence characterizes patients at high risk for multiple sclerosis after the initial neurological event.
  Proceedings of the National Academy of Sciences of the United States of America 2008 Corvol JC, Pelletier D, Henry RG, Caillier SJ, Wang J, Pappas D, Casazza S, Okuda DT, Hauser SL, Oksenberg JR, Baranzini SE
• An election season prescription for healthcare.
  Annals of neurology 2008 Hauser SL, Johnston SC
• Neurological disease on the global agenda.
  Annals of neurology 2008 Johnston SC, Hauser SL
• Genetic variation in nitric oxide synthase 2A (NOS2A) and risk for multiple sclerosis.
  Genes and immunity 2008 Barcellos LF, Ramsay PP, Caillier SJ, Sawcer S, Haines J, Schmidt S, Pericak-Vance M, Compston DA, Gabatto P, Hauser SL, Oksenberg JR
• The genetics of multiple sclerosis: SNPs to pathways to pathogenesis.
  Nature reviews. Genetics 2008 Oksenberg JR, Baranzini SE, Sawcer S, Hauser SL
• Kidney's nightshift, kidney's nightmare? Comparison of daylight and nighttime kidney transplantation: impact on complications and graft survival.
  Transplantation proceedings 2008 Fechner G, Pezold C, Hauser S, Gerhardt T, Müller SC
• That vexing problem of compensation.
  Annals of neurology 2008 Hauser SL, Johnston SC
• Transformative research.
  Annals of neurology 2008 Johnston SC, Hauser SL
• [The role of superselective transcatheter arterial embolisation in management of complications after kidney surgery].
  Aktuelle Urologie 2008 Fechner G, Hauser S, Flacke S, Gerhard T, Müller SC
• Electronic medical records: does it take a village or a thousand points of light?
  Annals of neurology 2008 Hauser SL, Johnston SC
• Cognitive and neurobiological alterations in electromagnetic hypersensitive patients: results of a case-control study.
  Psychological medicine 2008 Landgrebe M, Frick U, Hauser S, Langguth B, Rosner R, Hajak G, Eichhammer P
• T2 clinical research: judgment day.
  Annals of neurology 2008 Claiborne Johnston S, Hauser SL
• B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
  The New England journal of medicine 2008 Hauser SL, Waubant E, Arnold DL, Vollmer T, Antel J, Fox RJ, Bar-Or A, Panzara M, Sarkar N, Agarwal S, Langer-Gould A, Smith CH, HERMES Trial Group
• Neurogenetics in the Annals: dealing with complexity.
  Annals of neurology 2008 Oksenberg JR, Hauser SL
• Clinical trials: rising costs limit innovation.
  Annals of neurology 2007 Johnston SC, Hauser SL
• [Ureterocystoplasty in the treatment of "low-compliance" bladder in children].
  Der Urologe. Ausg. A 2007 Hauser S, Fisang C, Fechner F, Ellinger J, Haferkamp A, Müller SC
• The autoimmune disease-associated IL12B and IL23R polymorphisms in multiple sclerosis.
  Human immunology 2007 Begovich AB, Chang M, Caillier SJ, Lew D, Catanese JJ, Wang J, Hauser SL, Oksenberg JR
• The upcoming meeting of the ANA.
  Annals of neurology 2007 Hauser SL, Johnston SC
• SNPs in Multi-species Conserved Sequences (MCS) as useful markers in association studies: a practical approach.
  BMC genomics 2007 McCauley JL, Kenealy SJ, Margulies EH, Schnetz-Boutaud N, Gregory SG, Hauser SL, Oksenberg JR, Pericak-Vance MA, Haines JL, Mortlock DP
• Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis.
  Nature genetics 2007 Gregory SG, Schmidt S, Seth P, Oksenberg JR, Hart J, Prokop A, Caillier SJ, Ban M, Goris A, Barcellos LF, Lincoln R, McCauley JL, Sawcer SJ, Compston DA, Dubois B, Hauser SL, Garcia-Blanco MA, Pericak…
• Risk alleles for multiple sclerosis identified by a genomewide study.
  The New England journal of medicine 2007 International Multiple Sclerosis Genetics Consortium, Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, de Bakker PI, Gabriel SB, Mirel DB, Ivinson AJ, Pericak-Vance MA, Gregory SG, …
• Matriculating the next generation of clinician-scientists.
  Annals of neurology 2007 Hauser SL, Johnston SC
• Medical prizes: Lifetime achievement awards or engines for progress?
  Annals of neurology 2007 Hauser SL, Johnston SC
• Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring.
  The Lancet. Neurology 2007 Kappos L, Bates D, Hartung HP, Havrdova E, Miller D, Polman CH, Ravnborg M, Hauser SL, Rudick RA, Weiner HL, O'Connor PW, King J, Radue EW, Yousry T, Major EO, Clifford DB
• Early editorial manuscript screening versus obligate peer review: a randomized trial.
  Annals of neurology 2007 Johnston SC, Lowenstein DH, Ferriero DM, Messing RO, Oksenberg JR, Hauser SL
• A second major histocompatibility complex susceptibility locus for multiple sclerosis.
  Annals of neurology 2007 Yeo TW, De Jager PL, Gregory SG, Barcellos LF, Walton A, Goris A, Fenoglio C, Ban M, Taylor CJ, Goodman RS, Walsh E, Wolfish CS, Horton R, Traherne J, Beck S, Trowsdale J, Caillier SJ, Ivinson AJ, …
• Of ghosts and sirens: the subtlest lures of industry.
  Annals of neurology 2007 Hauser SL, Johnston SC
• Marketing and drug costs: who is laughing and crying?
  Annals of neurology 2007 Johnston SC, Hauser SL
• Familial effects on the clinical course of multiple sclerosis.
  Neurology 2007 Hensiek AE, Seaman SR, Barcellos LF, Oturai A, Eraksoi M, Cocco E, Vecsei L, Stewart G, Dubois B, Bellman-Strobl J, Leone M, Andersen O, Bencsik K, Booth D, Celius EG, Harbo HF, Hauser SL, Heard R, …
• A status report on neuroscience research, without grade inflation.
  Annals of neurology 2006 Johnston SC, Hauser SL
• Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study.
  The Lancet. Neurology 2006 Barcellos LF, Kamdar BB, Ramsay PP, DeLoa C, Lincoln RR, Caillier S, Schmidt S, Haines JL, Pericak-Vance MA, Oksenberg JR, Hauser SL
• Recombinant therapeutics: from bench to bedside (if your health plan concurs).
  Annals of neurology 2006 Hauser SL, Johnston SC
• The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration.
  Neuron 2006 Hauser SL, Oksenberg JR
• Neurology and medical devices.
  Annals of neurology 2006 Johnston SC, Hauser SL
• Complex gene-gene interactions in multiple sclerosis: a multifactorial approach reveals associations with inflammatory genes.
  Neurogenetics 2006 Motsinger AA, Brassat D, Caillier SJ, Erlich HA, Walker K, Steiner LL, Barcellos LF, Pericak-Vance MA, Schmidt S, Gregory S, Hauser SL, Haines JL, Oksenberg JR, Ritchie MD
• Saving the clinician-scientist: report of the ANA long range planning committee.
  Annals of neurology 2006 Hauser SL, McArthur JC
• Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
  Human molecular genetics 2006 Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, Briggs F, Cree BC, Begovich AB, Villoslada P, Montalban X, Uccelli A, Savettieri G, Lincoln RR, DeLoa C, Haines JL, Pericak-Vance MA, …
• Interleukin-2/interferon-alpha2a/13-retinoic acid-based chemoimmunotherapy in advanced renal cell carcinoma: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN).
  British journal of cancer 2006 Atzpodien J, Kirchner H, Rebmann U, Soder M, Gertenbach U, Siebels M, Roigas J, Raschke R, Salm S, Schwindl B, Müller SC, Hauser S, Leiber C, Huland E, Heinzer H, Siemer S, Metzner B, Heynemann H, …
• Men transmit MS more often to their children vs women: the Carter effect.
  Neurology 2006 Kantarci OH, Barcellos LF, Atkinson EJ, Ramsay PP, Lincoln R, Achenbach SJ, De Andrade M, Hauser SL, Weinshenker BG
• Basic and clinical research: what is the most appropriate weighting in a public investment portfolio?
  Annals of neurology 2006 Johnston SC, Hauser SL
• Allelic association of sequence variants in the herpes virus entry mediator-B gene (PVRL2) with the severity of multiple sclerosis.
  Genes and immunity 2006 Schmidt S, Pericak-Vance MA, Sawcer S, Barcellos LF, Hart J, Sims J, Prokop AM, van der Walt J, DeLoa C, Lincoln RR, Oksenberg JR, Compston A, Hauser SL, Haines JL, Gregory SG, Multiple Sclerosis …
• Sleepiness in the elderly.
  Annals of neurology 2006 Hauser SL
• [Primitive neuroectodermal tumor of the kidney].
  Der Urologe. Ausg. A 2006 Ellinger J, Bastian P, Hauser S, Biermann K, Müller S
• APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.
  Neurology 2006 Burwick RM, Ramsay PP, Haines JL, Hauser SL, Oksenberg JR, Pericak-Vance MA, Schmidt S, Compston A, Sawcer S, Cittadella R, Savettieri G, Quattrone A, Polman CH, Uitdehaag BM, Zwemmer JN, Hawkins CP, …
• Low-grade central nervous system lymphoma: clarity through a hazy lens.
  Annals of neurology 2006 Hauser SL
• Natalizumab: immune effects and implications for therapy.
  Annals of neurology 2006 Hauser SL, Weiner HL
• Multifactor dimensionality reduction reveals gene-gene interactions associated with multiple sclerosis susceptibility in African Americans.
  Genes and immunity 2006 Brassat D, Motsinger AA, Caillier SJ, Erlich HA, Walker K, Steiner LL, Cree BA, Barcellos LF, Pericak-Vance MA, Schmidt S, Gregory S, Hauser SL, Haines JL, Oksenberg JR, Ritchie MD
• Multiple sclerosis: tip of the iceberg?
  Annals of neurology 2006 Hauser SL
• Restrictive and diversifying elements of the anti-myelin/oligodendrocyte glycoprotein antibody response in primate experimental allergic encephalomyelitis.
  Immunogenetics 2006 von Büdingen HC, Menge T, Hauser SL, Genain CP
• Examination of seven candidate regions for multiple sclerosis: strong evidence of linkage to chromosome 1q44.
  Genes and immunity 2006 Kenealy SJ, Herrel LA, Bradford Y, Schnetz-Boutaud N, Oksenberg JR, Hauser SL, Barcellos LF, Schmidt S, Gregory SG, Pericak-Vance MA, Haines JL
• Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15.
  Human molecular genetics 2005 Traherne JA, Barcellos LF, Sawcer SJ, Compston A, Ramsay PP, Hauser SL, Oksenberg JR, Trowsdale J
• Mapping gene activity in complex disorders: Integration of expression and genomic scans for multiple sclerosis.
  Journal of neuroimmunology 2005 Fernald GH, Yeh RF, Hauser SL, Oksenberg JR, Baranzini SE
• Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations.
  Archives of neurology 2005 Frohman EM, Stüve O, Havrdova E, Corboy J, Achiron A, Zivadinov R, Sorensen PS, Phillips JT, Weinshenker B, Hawker K, Hartung HP, Steinman L, Zamvil S, Cree BA, Hauser S, Weiner H, Racke MK, Filippi M
• A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility.
  Nature genetics 2005 Reich D, Patterson N, De Jager PL, McDonald GJ, Waliszewska A, Tandon A, Lincoln RR, DeLoa C, Fruhan SA, Cabre P, Bera O, Semana G, Kelly MA, Francis DA, Ardlie K, Khan O, Cree BA, Hauser SL, …
• Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions.
  Archives of neurology 2005 Frohman EM, Filippi M, Stuve O, Waxman SG, Corboy J, Phillips JT, Lucchinetti C, Wilken J, Karandikar N, Hemmer B, Monson N, De Keyser J, Hartung H, Steinman L, Oksenberg JR, Cree BA, Hauser S, Racke …
• Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis.
  The Journal of allergy and clinical immunology 2005 Menge T, Lalive PH, von Büdingen HC, Cree B, Hauser SL, Genain CP
• A high-density screen for linkage in multiple sclerosis.
  American journal of human genetics 2005 Sawcer S, Ban M, Maranian M, Yeo TW, Compston A, Kirby A, Daly MJ, De Jager PL, Walsh E, Lander ES, Rioux JD, Hafler DA, Ivinson A, Rimmler J, Gregory SG, Schmidt S, Pericak-Vance MA, Akesson E, …
• Genetics of multiple sclerosis.
  Neurologic clinics 2005 Oksenberg JR, Hauser SL
• The HLA locus and multiple sclerosis in Sicily.
  Neurology 2005 Brassat D, Salemi G, Barcellos LF, McNeill G, Proia P, Hauser SL, Oksenberg JR, Savettieri G
• The R620W polymorphism of the protein tyrosine phosphatase PTPN22 is not associated with multiple sclerosis.
  American journal of human genetics 2005 Begovich AB, Caillier SJ, Alexander HC, Penko JM, Hauser SL, Barcellos LF, Oksenberg JR
• Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis.
  Neurology 2004 Cree BA, Khan O, Bourdette D, Goodin DS, Cohen JA, Marrie RA, Glidden D, Weinstock-Guttman B, Reich D, Patterson N, Haines JL, Pericak-Vance M, DeLoa C, Oksenberg JR, Hauser SL
• An update on multiple sclerosis.
  Journal of the neurological sciences 2004 Hauser SL
• A second-generation genomic screen for multiple sclerosis.
  American journal of human genetics 2004 Kenealy SJ, Babron MC, Bradford Y, Schnetz-Boutaud N, Haines JL, Rimmler JB, Schmidt S, Pericak-Vance MA, Barcellos LF, Lincoln RR, Oksenberg JR, Hauser SL, Clanet M, Brassat D, Edan G, Yaouanq J, …
• The shape of things to come.
  Neurology 2004 Hauser SL
• Frontline: Epitope recognition on the myelin/oligodendrocyte glycoprotein differentially influences disease phenotype and antibody effector functions in autoimmune demyelination.
  European journal of immunology 2004 von Büdingen HC, Hauser SL, Ouallet JC, Tanuma N, Menge T, Genain CP
• Re: GAMES issue.
  Journal of neuroimmunology 2004 Oksenberg JR, Hauser SL
• Enhancing linkage analysis of complex disorders: an evaluation of high-density genotyping.
  Human molecular genetics 2004 Sawcer SJ, Maranian M, Singlehurst S, Yeo T, Compston A, Daly MJ, De Jager PL, Gabriel S, Hafler DA, Ivinson AJ, Lander ES, Rioux JD, Walsh E, Gregory SG, Schmidt S, Pericak-Vance MA, Barcellos L, …
• Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis.
  Annals of neurology 2004 Barcellos LF, Begovich AB, Reynolds RL, Caillier SJ, Brassat D, Schmidt S, Grams SE, Walker K, Steiner LL, Cree BA, Stillman A, Lincoln RR, Pericak-Vance MA, Haines JL, Erlich HA, Hauser SL, Oksenberg…
• Methods for high-density admixture mapping of disease genes.
  American journal of human genetics 2004 Patterson N, Hattangadi N, Lane B, Lohmueller KE, Hafler DA, Oksenberg JR, Hauser SL, Smith MW, O'Brien SJ, Altshuler D, Daly MJ, Reich D
• Analysis of IL4R haplotypes in predisposition to multiple sclerosis.
  Genes and immunity 2004 Mirel DB, Barcellos LF, Wang J, Hauser SL, Oksenberg JR, Erlich HA
• Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.
  American journal of human genetics 2003 Oksenberg JR, Barcellos LF, Cree BA, Baranzini SE, Bugawan TL, Khan O, Lincoln RR, Swerdlin A, Mignot E, Lin L, Goodin D, Erlich HA, Schmidt S, Thomson G, Reich DE, Pericak-Vance MA, Haines JL, Hauser…
• Investigation of seven proposed regions of linkage in multiple sclerosis: an American and French collaborative study.
  Neurogenetics 2003 Pericak-Vance MA, Rimmler JB, Haines JL, Garcia ME, Oksenberg JR, Barcellos LF, Lincoln R, Hauser SL, Cournu-Rebeix I, Azoulay-Cayla A, Lyon-Caen O, Fontaine B, Duhamel E, Coppin H, Brassat D, Roth MP…
• Osteopontin polymorphisms and disease course in multiple sclerosis.
  Genes and immunity 2003 Caillier S, Barcellos LF, Baranzini SE, Swerdlin A, Lincoln RR, Steinman L, Martin E, Haines JL, Pericak-Vance M, Hauser SL, Oksenberg JR, Multiple Sclerosis Genetics Group
• Interferons in relapsing remitting multiple sclerosis.
  Lancet (London, England) 2003 Rudick RA, Cookfair DL, Griffin J, Hauser S, Piantadosi S
• Pharmacogenomic analysis of interferon receptor polymorphisms in multiple sclerosis.
  Genes and immunity 2003 Sriram U, Barcellos LF, Villoslada P, Rio J, Baranzini SE, Caillier S, Stillman A, Hauser SL, Montalban X, Oksenberg JR
• HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course.
  American journal of human genetics 2003 Barcellos LF, Oksenberg JR, Begovich AB, Martin ER, Schmidt S, Vittinghoff E, Goodin DS, Pelletier D, Lincoln RR, Bucher P, Swerdlin A, Pericak-Vance MA, Haines JL, Hauser SL, Multiple Sclerosis …
• Multiple susceptibility loci for multiple sclerosis.
  Human molecular genetics 2002 Haines JL, Bradford Y, Garcia ME, Reed AD, Neumeister E, Pericak-Vance MA, Rimmler JB, Menold MM, Martin ER, Oksenberg JR, Barcellos LF, Lincoln R, Hauser SL, Multiple Sclerosis Genetics Group
• Approved and future pharmacotherapy for multiple sclerosis.
  The neurologist 2002 Stüve O, Cree BC, von Büdingen HC, Yousef S, Bowen JD, Genain CP, Hauser SL, Steinman L, Zamvil SS
• The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-beta.
  Journal of neuroimmunology 2002 Villoslada P, Barcellos LF, Rio J, Begovich AB, Tintore M, Sastre-Garriga J, Baranzini SE, Casquero P, Hauser SL, Montalban X, Oksenberg JR
• Neuromyelitis optica.
  Seminars in neurology 2002 Cree BA, Goodin DS, Hauser SL
• The human T cell response to myelin oligodendrocyte glycoprotein: a multiple sclerosis family-based study.
  Journal of immunology (Baltimore, Md. : 1950) 2002 Koehler NK, Genain CP, Giesser B, Hauser SL
• Biological properties and molecular characterization of beet chlorosis virus (BChV).
  Archives of virology 2002 Hauser S, Stevens M, Beuve M, Lemaire O
• Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis.
  American journal of human genetics 2002 Schmidt S, Barcellos LF, DeSombre K, Rimmler JB, Lincoln RR, Bucher P, Saunders AM, Lai E, Martin ER, Vance JM, Oksenberg JR, Hauser SL, Pericak-Vance MA, Haines JL, Multiple Sclerosis Genetics Group
• Single nucleotide polymorphisms in MHC2TA, the gene encoding the MHC class II transactivator (CIITA).
  Genes and immunity 2002 Patarroyo JC, Stuve O, Piskurich JF, Hauser SL, Oksenberg JR, Zamvil SS
• Experimental allergic encephalomyelitis in the New World monkey Callithrix jacchus.
  Immunological reviews 2001 Genain CP, Hauser SL
• Linkage and association analysis of chromosome 19q13 in multiple sclerosis.
  Neurogenetics 2001 Pericak-Vance MA, Rimmler JB, Martin ER, Haines JL, Garcia ME, Oksenberg JR, Barcellos LF, Lincoln R, Goodkin DE, Hauser SL
• PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patients.
  Nature genetics 2001 Barcellos LF, Caillier S, Dragone L, Elder M, Vittinghoff E, Bucher P, Lincoln RR, Pericak-Vance M, Haines JL, Weiss A, Hauser SL, Oksenberg JR
• Multiple sclerosis and oligodendroglioma.
  Multiple sclerosis (Houndmills, Basingstoke, England) 2001 Green AJ, Bollen AW, Berger MS, Oksenberg JR, Hauser SL
• Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis.
  Archives of neurology 2001 Mohr DC, Goodkin DE, Islar J, Hauser SL, Genain CP
• Sequence variation in the transforming growth factor-beta1 (TGFB1) gene and multiple sclerosis susceptibility.
  Journal of neuroimmunology 2001 Green AJ, Barcellos LF, Rimmler JB, Garcia ME, Caillier S, Lincoln RR, Bucher P, Pericak-Vance MA, Haines JL, Hauser SL, Oksenberg JR, Multiple Sclerosis Genetics Group
• Multiple sclerosis: genomic rewards.
  Journal of neuroimmunology 2001 Oksenberg JR, Baranzini SE, Barcellos LF, Hauser SL
• Characterization of the response to myelin basic protein in a non human primate model for multiple sclerosis.
  European journal of immunology 2001 Uccelli A, Giunti D, Mancardi G, Caroli F, Fiorone M, Seri M, Hauser SL, Genain CP
• Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation.
  The Journal of biological chemistry 2000 Hauser S, Adelmant G, Sarraf P, Wright HM, Mueller E, Spiegelman BM
• Human nerve growth factor protects common marmosets against autoimmune encephalomyelitis by switching the balance of T helper cell type 1 and 2 cytokines within the central nervous system.
  The Journal of experimental medicine 2000 Villoslada P, Hauser SL, Bartke I, Unger J, Heald N, Rosenberg D, Cheung SW, Mobley WC, Fisher S, Genain CP
• Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study Group.
  Neurology 2000 Hauser SL, Oksenberg JR, Lincoln R, Garovoy J, Beck RW, Cole SR, Moke PS, Kip KE, Gal RL, Long DT
• CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group.
  Immunogenetics 2000 Barcellos LF, Schito AM, Rimmler JB, Vittinghoff E, Shih A, Lincoln R, Callier S, Elkins MK, Goodkin DE, Haines JL, Pericak-Vance MA, Hauser SL, Oksenberg JR
• A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation.
  The Journal of biological chemistry 2000 Wright HM, Clish CB, Mikami T, Hauser S, Yanagi K, Hiramatsu R, Serhan CN, Spiegelman BM
• Autoreactivity to myelin antigens: myelin/oligodendrocyte glycoprotein is a prevalent autoantigen.
  Journal of neuroimmunology 1999 Diaz-Villoslada P, Shih A, Shao L, Genain CP, Hauser SL
• Linkage analysis of candidate myelin genes in familial multiple sclerosis.
  Neurogenetics 1999 Seboun E, Oksenberg JR, Rombos A, Usuku K, Goodkin DE, Lincoln RR, Wong M, Pham-Dinh D, Boesplug-Tanguy O, Carsique R, Fitoussi R, Gartioux C, Reyes C, Ribierre F, Faure S, Fizames C, Gyapay G, …
• Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation.
  Annals of neurology 1999 Raine CS, Cannella B, Hauser SL, Genain CP
• An adipogenic cofactor bound by the differentiation domain of PPARgamma.
  The EMBO journal 1999 Castillo G, Brun RP, Rosenfield JK, Hauser S, Park CW, Troy AE, Wright ME, Spiegelman BM
• Identification of autoantibodies associated with myelin damage in multiple sclerosis.
  Nature medicine 1999 Genain CP, Cannella B, Hauser SL, Raine CS
• Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis.
  Brain : a journal of neurology 1998 Leppert D, Ford J, Stabler G, Grygar C, Lienert C, Huber S, Miller KM, Hauser SL, Kappos L
• Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. The Multiple Sclerosis Genetics Group.
  Human molecular genetics 1998 Haines JL, Terwedow HA, Burgess K, Pericak-Vance MA, Rimmler JB, Martin ER, Oksenberg JR, Lincoln R, Zhang DY, Banatao DR, Gatto N, Goodkin DE, Hauser SL
• Systemic lupus erythematosus (SLE) and neonatal morbidity and mortality.
  Australian and New Zealand journal of medicine 1998 Hauser S
• Transient 5-oxoprolinuria and high anion gap metabolic acidosis: clinical and biochemical findings in eleven subjects.
  Clinical chemistry 1998 Pitt JJ, Hauser S
• Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
  Diabetes 1998 Kwon G, Corbett JA, Hauser S, Hill JR, Turk J, McDaniel ML
• Multiple sclerosis: basic immunology.
  The journal of spinal cord medicine 1998 Hauser SL
• Characterization of the AD7C-NTP cDNA expression in Alzheimer's disease and measurement of a 41-kD protein in cerebrospinal fluid.
  The Journal of clinical investigation 1997 Monte SM, Ghanbari K, Frey WH, Beheshti I, Averback P, Hauser SL, Ghanbari HA, Wands JR
• Inhibition of allergic encephalomyelitis in marmosets by vaccination with recombinant vaccinia virus encoding for myelin basic protein.
  Journal of neuroimmunology 1997 Genain CP, Gritz L, Joshi N, Panicali D, Davis RL, Whitaker JN, Letvin NL, Hauser SL
• Autoimmune (idiopathic) thrombocytopenic purpura.
  Lancet (London, England) 1997 Hauser S
• Rapid identification of Smith-Lemli-Opitz syndrome homozygotes and heterozygotes (carriers) by measurement of deficient 7-dehydrocholesterol-delta 7-reductase activity in fibroblasts.
  Metabolism: clinical and experimental 1997 Shefer S, Salen G, Honda A, Batta A, Hauser S, Tint GS, Honda M, Chen T, Holick MF, Nguyen LB
• New insights into the immunogenetics of multiple sclerosis.
  Current opinion in neurology 1997 Oksenberg JR, Hauser SL
• Creation of a model for multiple sclerosis in Callithrix jacchus marmosets.
  Journal of molecular medicine (Berlin, Germany) 1997 Genain CP, Hauser SL
• Characterization of the TCRB chain repertoire in the New World monkey Callithrix jacchus.
  Journal of immunology (Baltimore, Md. : 1950) 1997 Uccelli A, Oksenberg JR, Jeong MC, Genain CP, Rombos T, Jaeger EE, Giunti D, Lanchbury JS, Hauser SL
• Local-clonal expansion of infiltrating T lymphocytes in chronic encephalitis of Rasmussen.
  Journal of immunology (Baltimore, Md. : 1950) 1997 Li Y, Uccelli A, Laxer KD, Jeong MC, Vinters HV, Tourtellotte WW, Hauser SL, Oksenberg JR
• Late complications of immune deviation therapy in a nonhuman primate.
  Science (New York, N.Y.) 1996 Genain CP, Abel K, Belmar N, Villinger F, Rosenberg DP, Linington C, Raine CS, Hauser SL
• Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis.
  Annals of neurology 1996 Leppert D, Waubant E, Bürk MR, Oksenberg JR, Hauser SL
• Biased expression of T cell receptor genes characterizes activated T cells in multiple sclerosis cerebrospinal fluid.
  Journal of neuroscience research 1996 Usuku K, Joshi N, Hatem CJ, Wong MA, Stein MC, Hauser SL
• Tumor necrosis factor (TNF) microsatellite haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex and TNF secretion.
  Human immunology 1996 Garcia-Merino A, Alper CA, Usuku K, Marcus-Bagley D, Lincoln R, Awdeh Z, Yunis EJ, Eisenbarth GS, Brink SJ, Hauser SL
• A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group.
  Nature genetics 1996 Haines JL, Ter-Minassian M, Bazyk A, Gusella JF, Kim DJ, Terwedow H, Pericak-Vance MA, Rimmler JB, Haynes CS, Roses AD, Lee A, Shaner B, Menold M, Seboun E, Fitoussi RP, Gartioux C, Reyes C, Ribierre …
• Genetics of demyelinating diseases.
  Brain pathology (Zurich, Switzerland) 1996 Oksenberg JR, Seboun E, Hauser SL
• Side effect profile of interferon beta-1b in MS: results of an open label trial.
  Neurology 1996 Neilley LK, Goodin DS, Goodkin DE, Hauser SL
• Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane.
  Journal of immunology (Baltimore, Md. : 1950) 1996 Xia M, Leppert D, Hauser SL, Sreedharan SP, Nelson PJ, Krensky AM, Goetzl EJ
• What to tell patients with their first attack of multiple sclerosis.
  European neurology 1996 Caplan LR, Achiron A, Hauser SL
• Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate.
  The Journal of clinical investigation 1995 Genain CP, Nguyen MH, Letvin NL, Pearl R, Davis RL, Adelman M, Lees MB, Linington C, Hauser SL
• Stimulation of matrix metalloproteinase-dependent migration of T cells by eicosanoids.
  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 1995 Leppert D, Hauser SL, Kishiyama JL, An S, Zeng L, Goetzl EJ
• Tumor necrosis factor: immunogenetics and disease.
  Annals of neurology 1995 Hauser SL
• T-cell receptor genes. Germline polymorphisms and genetic susceptibility to demyelinating diseases.
  Annals of the New York Academy of Sciences 1995 Hauser SL
• T cell gelatinases mediate basement membrane transmigration in vitro.
  Journal of immunology (Baltimore, Md. : 1950) 1995 Leppert D, Waubant E, Galardy R, Bunnett NW, Hauser SL
• Prevention of autoimmune demyelination in non-human primates by a cAMP-specific phosphodiesterase inhibitor.
  Proceedings of the National Academy of Sciences of the United States of America 1995 Genain CP, Roberts T, Davis RL, Nguyen MH, Uccelli A, Faulds D, Li Y, Hedgpeth J, Hauser SL
• Active and passively induced experimental autoimmune encephalomyelitis in common marmosets: a new model for multiple sclerosis.
  Annals of neurology 1995 Massacesi L, Genain CP, Lee-Parritz D, Letvin NL, Canfield D, Hauser SL
• Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients.
  Annals of neurology 1995 Rozniecki JJ, Hauser SL, Stein M, Lincoln R, Theoharides TC
• Expression and selective inhibition of constitutive and inducible forms of cyclooxygenase.
  Advances in prostaglandin, thromboxane, and leukotriene research 1995 Seibert K, Masferrer J, Zhang Y, Leahy K, Hauser S, Gierse J, Koboldt C, Anderson G, Bremer M, Gregory S
• Mediation of inflammation by cyclooxygenase-2.
  Agents and actions. Supplements 1995 Seibert K, Masferrer J, Zhang Y, Gregory S, Olson G, Hauser S, Leahy K, Perkins W, Isakson P
• Cytokine regulation of eicosanoid generation.
  Annals of the New York Academy of Sciences 1994 Isakson P, Hauser S, Zhang Y, Leahy K, Masferrer J, Seibert K
• Reexpression of the major histocompatibility complex (MHC) class-I antigen h-2k(b) by m1 (b16-f10) murine melanoma-cells.
  International journal of oncology 1994 Calorini L, Simile M, Hauser S, Gattonicelli S
• Future role of neurologists.
  The Western journal of medicine 1994 Engstrom JW, Hauser SL
• In healthy primates, circulating autoreactive T cells mediate autoimmune disease.
  The Journal of clinical investigation 1994 Genain CP, Lee-Parritz D, Nguyen MH, Massacesi L, Joshi N, Ferrante R, Hoffman K, Moseley M, Letvin NL, Hauser SL
• Prevention strategies for multiple sclerosis.
  Annals of neurology 1994 Hauser SL
• The T-cell response to myelin basic protein in familial multiple sclerosis: diversity of fine specificity, restricting elements, and T-cell receptor usage.
  Annals of neurology 1993 Joshi N, Usuku K, Hauser SL
• Unusual organization of the human T-cell receptor beta-chain gene complex is linked to recombination hotspots.
  Proceedings of the National Academy of Sciences of the United States of America 1993 Seboun E, Houghton L, Hatem CJ, Lincoln R, Hauser SL
• Human ciliary neurotrophic factor: localization to the proximal region of the long arm of chromosome 11 and association with CA/GT dinucleotide repeat.
  Genomics 1993 Lev AA, Rosen DR, Kos C, Clifford E, Landes G, Hauser SL, Brown RH
• Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group.
  Neurology 1993 Weiner HL, Mackin GA, Orav EJ, Hafler DA, Dawson DM, LaPierre Y, Herndon R, Lehrich JR, Hauser SL, Turel A
• A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta.
  Growth factors (Chur, Switzerland) 1993 Hauser S, Weich HA
• Segregation of immunoglobulin heavy chain constant region genes in multiple sclerosis sibling pairs.
  Journal of neuroimmunology 1993 Yu JS, Pandey JP, Massacesi L, Lincoln R, Usuku K, Seboun E, Hauser SL
• The human T-cell receptor beta-chain repertoire: longitudinal fluctuations and assessment in MHC matched populations.
  Immunogenetics 1993 Usuku K, Joshi N, Hatem CJ, Alper CA, Schoenfeld DA, Hauser SL
• Increased levels of neuronal thread protein in cerebrospinal fluid of patients with Alzheimer's disease.
  Annals of neurology 1992 de la Monte SM, Volicer L, Hauser SL, Wands JR
• An antispasticity effect of threonine in multiple sclerosis.
  Archives of neurology 1992 Hauser SL, Doolittle TH, Lopez-Bresnahan M, Shahani B, Schoenfeld D, Shih VE, Growdon J, Lehrich JR
• Experimental allergic encephalomyelitis in cynomolgus monkeys. Quantitation of T cell responses in peripheral blood.
  The Journal of clinical investigation 1992 Massacesi L, Joshi N, Lee-Parritz D, Rombos A, Letvin NL, Hauser SL
• Haplotypic origin of beta-chain genes expressed by human T-cell clones.
  Immunogenetics 1992 Seboun E, Joshi N, Hauser SL
• T-cell receptors: germline polymorphism and patterns of usage in demyelinating diseases.
  Critical reviews in immunology 1992 Usuku K, Joshi N, Hauser SL
• Fos RNA accumulation in multiple sclerosis white matter tissue.
  Journal of the neurological sciences 1991 Yu JS, Hayashi T, Seboun E, Sklar RM, Doolittle TH, Hauser SL
• The role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocriptine.
  Annals of neurology 1991 Riskind PN, Massacesi L, Doolittle TH, Hauser SL
• Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6.
  Neurology 1990 Hauser SL, Doolittle TH, Lincoln R, Brown RH, Dinarello CA
• Multiple sclerosis sibling pairs: clustered onset and familial predisposition.
  Neurology 1990 Doolittle TH, Myers RH, Lehrich JR, Birnbaum G, Sheremata W, Franklin GM, Nelson LM, Hauser SL
• Substance P immunoreactive astrocytes are present in multiple sclerosis plaques.
  Brain research 1989 Kostyk SK, Kowall NW, Hauser SL
• Insertion/deletion-related polymorphisms in the human T cell receptor beta gene complex.
  The Journal of experimental medicine 1989 Seboun E, Robinson MA, Kindt TJ, Hauser SL
• Suppression of antibody responses to the acetylcholine receptor by natural antibodies.
  European journal of immunology 1989 Sundblad A, Hauser S, Holmberg D, Cazenave PA, Coutinho A
• [Retrospective marker analyses performed with blood and bone marrow smears using an immunoenzyme procedure (alkaline phosphatase-anti-alkaline phosphatase technic)].
  Klinische Padiatrie 1989 Ebener U, Hauser S, Wehner S, Kornhuber B
• A susceptibility locus for multiple sclerosis is linked to the T cell receptor beta chain complex.
  Cell 1989 Seboun E, Robinson MA, Doolittle TH, Ciulla TA, Kindt TJ, Hauser SL
• Extended major histocompatibility complex haplotypes in patients with multiple sclerosis.
  Neurology 1989 Hauser SL, Fleischnick E, Weiner HL, Marcus D, Awdeh Z, Yunis EJ, Alper CA
• Competitive inhibition of bile acid synthesis by endogenous cholestanol and sitosterol in sitosterolemia with xanthomatosis. Effect on cholesterol 7 alpha-hydroxylase.
  The Journal of clinical investigation 1988 Shefer S, Salen G, Nguyen L, Batta AK, Packin V, Tint GS, Hauser S
• A simple method for DNA purification from peripheral blood.
  Analytical biochemistry 1988 Ciulla TA, Sklar RM, Hauser SL
• Dual-label immunocytochemistry of the active multiple sclerosis lesion: major histocompatibility complex and activation antigens.
  Annals of neurology 1988 Hayashi T, Morimoto C, Burks JS, Kerr C, Hauser SL
• Expression and cellular localization of major histocompatibility complex antigens in active multiple sclerosis lesions.
  Annals of the New York Academy of Sciences 1988 Hayashi T, Burks JS, Hauser SL
• Molecular genotypes of the T-cell receptor beta chain in families with multiple sclerosis.
  Annals of the New York Academy of Sciences 1988 Ciulla TA, Robinson MA, Seboun E, Doolittle TH, Hayashi T, Kindt TJ, Hauser SL
• Immunoregulatory abnormalities induced by experimental reovirus infection: functional alterations in T-cell subpopulations.
  Clinical immunology and immunopathology 1987 Hauser SL, Che M, Fallis RJ, Weiner HL
• Extracts of muscle biopsies from patients with spinal muscular atrophies inhibit neurite outgrowth from spinal neurons.
  Neurology 1987 Henderson CE, Hauser SL, Huchet M, Dessi F, Hentati F, Taguchi T, Changeux JP, Fardeau M
• Immunoblot analysis of circulating antibodies against muscle proteins in amyotrophic lateral sclerosis and other neurologic diseases.
  Neurology 1986 Hauser SL, Cazenave PA, Lyon-Caen O, Taguchi T, Huchet M, Nuret H, Changeux JP, Henderson CE
• Cognitive function in recent-onset demyelinating diseases.
  Archives of neurology 1986 Lyon-Caen O, Jouvent R, Hauser S, Chaunu MP, Benoit N, Widlöcher D, Lhermitte F
• Analysis of human T-lymphotrophic virus sequences in multiple sclerosis tissue.
  Nature 1986 Hauser SL, Aubert C, Burks JS, Kerr C, Lyon-Caen O, de The G, Brahic M
• Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions.
  Annals of neurology 1986 Hauser SL, Bhan AK, Gilles F, Kemp M, Kerr C, Weiner HL
• Failure of immunosuppression with a ten- to 14-day course of high-dose intravenous cyclophosphamide to alter the progression of amyotrophic lateral sclerosis.
  Archives of neurology 1986 Brown RH, Hauser SL, Harrington H, Weiner HL
• Increased IgG secretion by unstimulated mononuclear cells in active multiple sclerosis and functional assessment of the T8 subset.
  Clinical immunology and immunopathology 1985 Hauser SL, Ault KA, Johnson D, Hoban C, Weiner HL
• Redistribution of Lyt-bearing T cells in acute murine experimental allergic encephalomyelitis: selective migration of Lyt-1 cells to the central nervous system is associated with a transient depletion of Lyt-1 cells in peripheral blood.
  Journal of immunology (Baltimore, Md. : 1950) 1984 Hauser SL, Bahn AK, Che M, Gilles F, Weiner HL
• Comparative effects of cholestanol and cholesterol on hepatic sterol and bile acid metabolism in the rat.
  The Journal of clinical investigation 1984 Shefer S, Hauser S, Salen G, Zaki FG, Bullock J, Salgado E, Shevitz J
• Lyt-1 cells mediate acute murine experimental allergic encephalomyelitis.
  Journal of immunology (Baltimore, Md. : 1950) 1984 Hauser SL, Weiner HL, Bhan AK, Shapiro ME, Che M, Aldrich WR, Letvin NL
• Lymphocytapheresis in chronic progressive multiple sclerosis: immunologic and clinical effects.
  Neurology 1984 Hauser SL, Fosburg M, Kevy SV, Weiner HL
• Autoimmunity following viral infection: demonstration of monoclonal antibodies against normal tissue following infection of mice with reovirus and demonstration of shared antigenicity between virus and lymphocytes.
  European journal of immunology 1984 Tardieu M, Powers ML, Hafler DA, Hauser SL, Weiner HL
• Altered blood T-cell subsets in patients with multiple sclerosis.
  Journal of neuroimmunology 1984 Weiner HL, Hafler DA, Fallis RJ, Johnson D, Ault KA, Hauser SL
• Prevention of experimental allergic encephalomyelitis (EAE) in the SJL/J mouse by whole body ultraviolet irradiation.
  Journal of immunology (Baltimore, Md. : 1950) 1984 Hauser SL, Weiner HL, Che M, Shapiro ME, Gilles F, Letvin NL
• T cell subsets in patients with multiple sclerosis. An overview.
  Annals of the New York Academy of Sciences 1984 Weiner HL, Hafler DA, Fallis RJ, Johnson D, Ault KA, Hauser SL
• The use of cyclophosphamide in the treatment of multiple sclerosis.
  Annals of the New York Academy of Sciences 1984 Weiner HL, Hauser SL, Hafler DA, Fallis RJ, Lehrich JR, Dawson DM
• Immunosuppression and plasmapheresis in chronic progressive multiple sclerosis. Design of a clinical trial.
  Archives of neurology 1983 Hauser SL, Dawson DM, Lehrich JR, Beal MF, Kevy SV, Weiner HL
• Immunohistochemical staining of human brain with monoclonal antibodies that identify lymphocytes, monocytes, and the Ia antigen.
  Journal of neuroimmunology 1983 Hauser SL, Bhan AK, Gilles FH, Hoban CJ, Reinherz EL, Schlossman SF, Weiner HL
• Epinephrine-induced changes in the distribution of lymphocyte subsets in peripheral blood of humans.
  Journal of immunology (Baltimore, Md. : 1950) 1983 Crary B, Hauser SL, Borysenko M, Kutz I, Hoban C, Ault KA, Weiner HL, Benson H
• CSF cells in multiple sclerosis: monoclonal antibody analysis and relationship to peripheral blood T-cell subsets.
  Neurology 1983 Hauser SL, Reinherz EL, Hoban CJ, Schlossman SF, Weiner HL
• Immunoregulatory T-cells and lymphocytotoxic antibodies in active multiple sclerosis: weekly analysis over a six-month period.
  Annals of neurology 1983 Hauser SL, Reinherz EL, Hoban CJ, Schlossman SF, Weiner HL
• Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.
  The New England journal of medicine 1983 Hauser SL, Dawson DM, Lehrich JR, Beal MF, Kevy SV, Propper RD, Mills JA, Weiner HL
• Immunoregulation in multiple sclerosis.
  Progress in brain research 1983 Weiner HL, Hauser SL
• Neuroimmunology. II: Antigenic specificity of the nervous system.
  Annals of neurology 1982 Weiner HL, Hauser SL
• T-cell subsets in human autoimmune diseases.
  Neurology 1982 Hauser SL, Ropper AH, Perlo VP, Reinherz EL, Schlossman SF, Weiner HL
• Childhood multiple sclerosis: clinical features and demonstration of changes in T cell subsets with disease activity.
  Annals of neurology 1982 Hauser SL, Bresnan MJ, Reinherz EL, Weiner HL
• Neuroimmunology I: Immunoregulation in neurological disease.
  Annals of neurology 1982 Weiner HL, Hauser SL
• Clonally restricted B cells in peripheral blood of multiple sclerosis patients: kappa/lambda staining patterns.
  Annals of neurology 1982 Hauser SL, Weiner HL, Ault KA
• Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
  Progress in clinical and biological research 1982 Hauser SL, Fosburg M, Kevy S, Weiner HL
• Natural killer cell activity in multiple sclerosis.
  Journal of immunology (Baltimore, Md. : 1950) 1981 Hauser SL, Ault KA, Levin MJ, Garovoy MR, Weiner HL
• Autism and mental retardation: neuropathologic studies performed in four retarded persons with autistic behavior.
  Archives of neurology 1980 Williams RS, Hauser SL, Purpura DP, DeLong GR, Swisher CN
• Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies.
  The New England journal of medicine 1980 Reinherz EL, Weiner HL, Hauser SL, Cohen JA, Distaso JA, Schlossman SF
• Lymphocyte capping in muscular dystrophy.
  Neurology 1979 Hauser SL, Weiner HL, Bresnan MJ, Ault KA
• A 25-hydroxylation pathway of cholic acid biosynthesis in man and rat.
  The Journal of clinical investigation 1976 Shefer S, Cheng FW, Dayal B, Hauser S, Tint GS, Salen G, Mosbach EH
• Pneumographic findings in the infantile autism syndrome. A correlation with temporal lobe disease.
  Brain : a journal of neurology 1975 Hauser SL, DeLong GR, Rosman NP